id	sid	tid	token	lemma	pos
egc-267	1	1	eglobal	eglobal	PROPN
egc-267	1	2	congress	congress	PROPN
egc-267	1	3	hosted	host	VERB
egc-267	1	4	online	online	ADV
egc-267	1	5	from	from	ADP
egc-267	1	6	dubai	dubai	PROPN
egc-267	1	7	,	,	PUNCT
egc-267	1	8	u.	u.	PROPN
egc-267	1	9	a.	a.	PROPN
egc-267	1	10	e.	e.	PROPN
egc-267	1	11	,	,	PUNCT
egc-267	1	12	e	e	PROPN
egc-267	1	13	conference	conference	NOUN
egc-267	1	14	.	.	PUNCT
egc-267	2	1	date	date	NOUN
egc-267	2	2	:	:	PUNCT
egc-267	2	3	29th	29th	ADJ
egc-267	2	4	october	october	PROPN
egc-267	2	5	2024	2024	NUM
egc-267	2	6	website	website	NOUN
egc-267	2	7	:	:	PUNCT
egc-267	2	8	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-267	2	9	issn	issn	PROPN
egc-267	2	10	(	(	PUNCT
egc-267	2	11	e	e	NOUN
egc-267	2	12	):	):	PUNCT
egc-267	2	13	2836	2836	NUM
egc-267	2	14	-	-	SYM
egc-267	2	15	3612	3612	NUM
egc-267	2	16	74	74	NUM
egc-267	3	1	|	|	ADV
egc-267	3	2	p	p	NOUN
egc-267	3	3	a	a	DET
egc-267	3	4	g	g	NOUN
egc-267	3	5	e	e	NOUN
egc-267	3	6	me	me	PROPN
egc-267	3	7	/	/	SYM
egc-267	3	8	cfs	cfs	PROPN
egc-267	3	9	and	and	CCONJ
egc-267	3	10	long	long	ADJ
egc-267	3	11	covid	covid	VERB
egc-267	3	12	–	–	PUNCT
egc-267	3	13	similarities	similarity	NOUN
egc-267	3	14	and	and	CCONJ
egc-267	3	15	differences	difference	NOUN
egc-267	3	16	in	in	ADP
egc-267	3	17	the	the	DET
egc-267	3	18	background	background	NOUN
egc-267	3	19	of	of	ADP
egc-267	3	20	the	the	DET
egc-267	3	21	world	world	NOUN
egc-267	3	22	situation	situation	NOUN
egc-267	3	23	:	:	PUNCT
egc-267	3	24	a	a	DET
egc-267	3	25	review	review	NOUN
egc-267	3	26	keti	keti	PROPN
egc-267	3	27	kebadze1	kebadze1	PROPN
egc-267	3	28	,	,	PUNCT
egc-267	3	29	mariam	mariam	PROPN
egc-267	3	30	gigiadze1	gigiadze1	PROPN
egc-267	3	31	,	,	PUNCT
egc-267	3	32	melita	melita	PROPN
egc-267	3	33	modebadze2	modebadze2	PROPN
egc-267	3	34	,	,	PUNCT
egc-267	3	35	mariam	mariam	PROPN
egc-267	3	36	beriashvili1	beriashvili1	PROPN
egc-267	3	37	,	,	PUNCT
egc-267	3	38	elene	elene	PROPN
egc-267	3	39	vardosanidze3	vardosanidze3	PROPN
egc-267	3	40	,	,	PUNCT
egc-267	3	41	indira	indira	PROPN
egc-267	3	42	kvirkvelia2	kvirkvelia2	PROPN
egc-267	3	43	,	,	PUNCT
egc-267	3	44	nino	nino	PROPN
egc-267	3	45	nadiradze2	nadiradze2	PROPN
egc-267	3	46	.	.	PUNCT
egc-267	4	1	1	1	NUM
egc-267	4	2	tbilisi	tbilisi	PROPN
egc-267	4	3	state	state	PROPN
egc-267	4	4	medical	medical	PROPN
egc-267	4	5	university	university	NOUN
egc-267	4	6	,	,	PUNCT
egc-267	4	7	faculty	faculty	NOUN
egc-267	4	8	of	of	ADP
egc-267	4	9	medicine	medicine	NOUN
egc-267	4	10	,	,	PUNCT
egc-267	4	11	tbilisi	tbilisi	PROPN
egc-267	4	12	,	,	PUNCT
egc-267	4	13	georgia	georgia	PROPN
egc-267	4	14	;	;	PUNCT
egc-267	4	15	2	2	NUM
egc-267	4	16	caucasus	caucasus	PROPN
egc-267	4	17	international	international	PROPN
egc-267	4	18	university	university	PROPN
egc-267	4	19	,	,	PUNCT
egc-267	4	20	faculty	faculty	NOUN
egc-267	4	21	of	of	ADP
egc-267	4	22	medicine	medicine	NOUN
egc-267	4	23	,	,	PUNCT
egc-267	4	24	tbilisi	tbilisi	PROPN
egc-267	4	25	,	,	PUNCT
egc-267	4	26	georgia	georgia	PROPN
egc-267	4	27	;	;	PUNCT
egc-267	4	28	3	3	NUM
egc-267	4	29	tbilisi	tbilisi	PROPN
egc-267	4	30	state	state	PROPN
egc-267	4	31	medical	medical	PROPN
egc-267	4	32	university	university	NOUN
egc-267	4	33	,	,	PUNCT
egc-267	4	34	faculty	faculty	NOUN
egc-267	4	35	of	of	ADP
egc-267	4	36	public	public	ADJ
egc-267	4	37	health	health	NOUN
egc-267	4	38	,	,	PUNCT
egc-267	4	39	tbilisi	tbilisi	PROPN
egc-267	4	40	,	,	PUNCT
egc-267	4	41	georgia	georgia	PROPN
egc-267	4	42	;	;	PUNCT
egc-267	4	43	supervisors	supervisor	NOUN
egc-267	4	44	:	:	PUNCT
egc-267	4	45	devi	devi	PROPN
egc-267	4	46	tabidze1	tabidze1	PROPN
egc-267	4	47	,	,	PUNCT
egc-267	4	48	erekle	erekle	ADV
egc-267	4	49	gigiadze2	gigiadze2	VERB
egc-267	5	1	1tbilisi	1tbilisi	NUM
egc-267	5	2	state	state	NOUN
egc-267	5	3	medical	medical	ADJ
egc-267	5	4	university	university	NOUN
egc-267	5	5	,	,	PUNCT
egc-267	5	6	department	department	NOUN
egc-267	5	7	of	of	ADP
egc-267	5	8	public	public	ADJ
egc-267	5	9	health	health	NOUN
egc-267	5	10	,	,	PUNCT
egc-267	5	11	management	management	NOUN
egc-267	5	12	policy	policy	NOUN
egc-267	5	13	and	and	CCONJ
egc-267	5	14	economics	economic	NOUN
egc-267	5	15	,	,	PUNCT
egc-267	5	16	assistant	assistant	NOUN
egc-267	5	17	-	-	PUNCT
egc-267	5	18	professor	professor	NOUN
egc-267	5	19	,	,	PUNCT
egc-267	5	20	tbilisi	tbilisi	PROPN
egc-267	5	21	,	,	PUNCT
egc-267	5	22	georgia	georgia	PROPN
egc-267	5	23	;	;	PUNCT
egc-267	5	24	2	2	NUM
egc-267	5	25	md	md	PROPN
egc-267	5	26	.	.	PUNCT
egc-267	5	27	phd	phd	PROPN
egc-267	5	28	.	.	PUNCT
egc-267	5	29	k.	k.	PROPN
egc-267	5	30	eristavi	eristavi	VERB
egc-267	5	31	national	national	ADJ
egc-267	5	32	center	center	NOUN
egc-267	5	33	of	of	ADP
egc-267	5	34	experimental	experimental	ADJ
egc-267	5	35	and	and	CCONJ
egc-267	5	36	clinical	clinical	ADJ
egc-267	5	37	surgery	surgery	NOUN
egc-267	5	38	.	.	PUNCT
egc-267	6	1	tbilisi	tbilisi	PROPN
egc-267	6	2	,	,	PUNCT
egc-267	6	3	georgia	georgia	PROPN
egc-267	6	4	abstract	abstract	NOUN
egc-267	6	5	:	:	PUNCT
egc-267	6	6	the	the	DET
egc-267	6	7	global	global	ADJ
egc-267	6	8	prevalence	prevalence	NOUN
egc-267	6	9	of	of	ADP
egc-267	6	10	covid-19	covid-19	PROPN
egc-267	6	11	and	and	CCONJ
egc-267	6	12	chronic	chronic	ADJ
egc-267	6	13	fatigue	fatigue	NOUN
egc-267	6	14	syndrome	syndrome	NOUN
egc-267	6	15	(	(	PUNCT
egc-267	6	16	cfs	cfs	PROPN
egc-267	6	17	)	)	PUNCT
egc-267	6	18	highlights	highlight	VERB
egc-267	6	19	the	the	DET
egc-267	6	20	substantial	substantial	ADJ
egc-267	6	21	health	health	NOUN
egc-267	6	22	burden	burden	NOUN
egc-267	6	23	these	these	DET
egc-267	6	24	conditions	condition	NOUN
egc-267	6	25	pose	pose	VERB
egc-267	6	26	individually	individually	ADV
egc-267	6	27	and	and	CCONJ
egc-267	6	28	in	in	ADP
egc-267	6	29	combination	combination	NOUN
egc-267	6	30	.	.	PUNCT
egc-267	7	1	covid-19	covid-19	PROPN
egc-267	7	2	,	,	PUNCT
egc-267	7	3	caused	cause	VERB
egc-267	7	4	by	by	ADP
egc-267	7	5	sars	sar	NOUN
egc-267	7	6	-	-	PUNCT
egc-267	7	7	cov-2	cov-2	NOUN
egc-267	7	8	,	,	PUNCT
egc-267	7	9	continues	continue	VERB
egc-267	7	10	to	to	PART
egc-267	7	11	affect	affect	VERB
egc-267	7	12	millions	million	NOUN
egc-267	7	13	worldwide	worldwide	ADV
egc-267	7	14	,	,	PUNCT
egc-267	7	15	with	with	ADP
egc-267	7	16	post	post	ADJ
egc-267	7	17	-	-	ADJ
egc-267	7	18	acute	acute	ADJ
egc-267	7	19	sequelae	sequelae	NOUN
egc-267	7	20	,	,	PUNCT
egc-267	7	21	known	know	VERB
egc-267	7	22	as	as	ADP
egc-267	7	23	long	long	ADJ
egc-267	7	24	covid	covid	NOUN
egc-267	7	25	,	,	PUNCT
egc-267	7	26	impacting	impact	VERB
egc-267	7	27	an	an	DET
egc-267	7	28	estimated	estimate	VERB
egc-267	7	29	5	5	NUM
egc-267	7	30	-	-	SYM
egc-267	7	31	43	43	NUM
egc-267	7	32	%	%	NOUN
egc-267	7	33	of	of	ADP
egc-267	7	34	recovered	recovered	ADJ
egc-267	7	35	individuals	individual	NOUN
egc-267	7	36	.	.	PUNCT
egc-267	8	1	among	among	ADP
egc-267	8	2	these	these	PRON
egc-267	8	3	,	,	PUNCT
egc-267	8	4	chronic	chronic	ADJ
egc-267	8	5	fatigue	fatigue	NOUN
egc-267	8	6	is	be	AUX
egc-267	8	7	a	a	DET
egc-267	8	8	prominent	prominent	ADJ
egc-267	8	9	and	and	CCONJ
egc-267	8	10	persistent	persistent	ADJ
egc-267	8	11	symptom	symptom	NOUN
egc-267	8	12	,	,	PUNCT
egc-267	8	13	with	with	ADP
egc-267	8	14	42.5	42.5	NUM
egc-267	8	15	%	%	NOUN
egc-267	8	16	of	of	ADP
egc-267	8	17	long	long	ADJ
egc-267	8	18	covid	covid	NOUN
egc-267	8	19	patients	patient	NOUN
egc-267	8	20	experiencing	experience	VERB
egc-267	8	21	fatigue	fatigue	NOUN
egc-267	8	22	that	that	PRON
egc-267	8	23	can	can	AUX
egc-267	8	24	resemble	resemble	VERB
egc-267	8	25	cfs	cfs	PROPN
egc-267	8	26	.	.	PUNCT
egc-267	9	1	chronic	chronic	ADJ
egc-267	9	2	fatigue	fatigue	NOUN
egc-267	9	3	syndrome	syndrome	NOUN
egc-267	9	4	(	(	PUNCT
egc-267	9	5	cfs	cfs	PROPN
egc-267	9	6	)	)	PUNCT
egc-267	9	7	,	,	PUNCT
egc-267	9	8	affecting	affect	VERB
egc-267	9	9	an	an	DET
egc-267	9	10	estimated	estimate	VERB
egc-267	9	11	0.4	0.4	NUM
egc-267	9	12	%	%	NOUN
egc-267	9	13	to	to	ADP
egc-267	9	14	2.5	2.5	NUM
egc-267	9	15	%	%	NOUN
egc-267	9	16	of	of	ADP
egc-267	9	17	the	the	DET
egc-267	9	18	global	global	ADJ
egc-267	9	19	population	population	NOUN
egc-267	9	20	,	,	PUNCT
egc-267	9	21	is	be	AUX
egc-267	9	22	marked	mark	VERB
egc-267	9	23	by	by	ADP
egc-267	9	24	enduring	endure	VERB
egc-267	9	25	,	,	PUNCT
egc-267	9	26	debilitating	debilitate	VERB
egc-267	9	27	fatigue	fatigue	NOUN
egc-267	9	28	often	often	ADV
egc-267	9	29	triggered	trigger	VERB
egc-267	9	30	by	by	ADP
egc-267	9	31	infections	infection	NOUN
egc-267	9	32	.	.	PUNCT
egc-267	10	1	emerging	emerge	VERB
egc-267	10	2	data	datum	NOUN
egc-267	10	3	suggest	suggest	VERB
egc-267	10	4	that	that	SCONJ
egc-267	10	5	sars	sar	NOUN
egc-267	10	6	-	-	PUNCT
egc-267	10	7	cov-2	cov-2	PART
egc-267	10	8	may	may	AUX
egc-267	10	9	exacerbate	exacerbate	VERB
egc-267	10	10	or	or	CCONJ
egc-267	10	11	reveal	reveal	VERB
egc-267	10	12	latent	latent	NOUN
egc-267	10	13	cfs	cfs	NOUN
egc-267	10	14	-	-	PUNCT
egc-267	10	15	like	like	ADJ
egc-267	10	16	symptoms	symptom	NOUN
egc-267	10	17	,	,	PUNCT
egc-267	10	18	linking	link	VERB
egc-267	10	19	these	these	DET
egc-267	10	20	conditions	condition	NOUN
egc-267	10	21	biologically	biologically	ADV
egc-267	10	22	and	and	CCONJ
egc-267	10	23	symptomatically	symptomatically	ADV
egc-267	10	24	.	.	PUNCT
egc-267	11	1	given	give	VERB
egc-267	11	2	the	the	DET
egc-267	11	3	shared	share	VERB
egc-267	11	4	features	feature	NOUN
egc-267	11	5	of	of	ADP
egc-267	11	6	immune	immune	ADJ
egc-267	11	7	dysregulation	dysregulation	NOUN
egc-267	11	8	and	and	CCONJ
egc-267	11	9	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-267	11	10	eglobal	eglobal	PROPN
egc-267	11	11	congress	congress	PROPN
egc-267	11	12	hosted	host	VERB
egc-267	11	13	online	online	ADV
egc-267	11	14	from	from	ADP
egc-267	11	15	dubai	dubai	PROPN
egc-267	11	16	,	,	PUNCT
egc-267	11	17	u.	u.	PROPN
egc-267	11	18	a.	a.	PROPN
egc-267	11	19	e.	e.	PROPN
egc-267	11	20	,	,	PUNCT
egc-267	11	21	e	e	PROPN
egc-267	11	22	conference	conference	NOUN
egc-267	11	23	.	.	PUNCT
egc-267	12	1	date	date	NOUN
egc-267	12	2	:	:	PUNCT
egc-267	12	3	29th	29th	ADJ
egc-267	12	4	october	october	PROPN
egc-267	12	5	2024	2024	NUM
egc-267	12	6	website	website	NOUN
egc-267	12	7	:	:	PUNCT
egc-267	12	8	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-267	12	9	issn	issn	PROPN
egc-267	12	10	(	(	PUNCT
egc-267	12	11	e	e	NOUN
egc-267	12	12	):	):	PUNCT
egc-267	12	13	2836	2836	NUM
egc-267	12	14	-	-	SYM
egc-267	12	15	3612	3612	NUM
egc-267	12	16	75	75	NUM
egc-267	12	17	|	|	ADV
egc-267	12	18	p	p	X
egc-267	12	19	a	a	DET
egc-267	12	20	g	g	NOUN
egc-267	12	21	e	e	NOUN
egc-267	12	22	fatigue	fatigue	NOUN
egc-267	12	23	in	in	ADP
egc-267	12	24	both	both	DET
egc-267	12	25	conditions	condition	NOUN
egc-267	12	26	,	,	PUNCT
egc-267	12	27	this	this	DET
egc-267	12	28	paper	paper	NOUN
egc-267	12	29	reviews	review	VERB
egc-267	12	30	their	their	PRON
egc-267	12	31	epidemiological	epidemiological	ADJ
egc-267	12	32	profiles	profile	NOUN
egc-267	12	33	and	and	CCONJ
egc-267	12	34	underscores	underscore	VERB
egc-267	12	35	the	the	DET
egc-267	12	36	need	need	NOUN
egc-267	12	37	for	for	ADP
egc-267	12	38	enhanced	enhanced	ADJ
egc-267	12	39	diagnostic	diagnostic	ADJ
egc-267	12	40	criteria	criterion	NOUN
egc-267	12	41	,	,	PUNCT
egc-267	12	42	research	research	NOUN
egc-267	12	43	,	,	PUNCT
egc-267	12	44	and	and	CCONJ
egc-267	12	45	support	support	NOUN
egc-267	12	46	systems	system	NOUN
egc-267	12	47	.	.	PUNCT
egc-267	13	1	improved	improve	VERB
egc-267	13	2	understanding	understanding	NOUN
egc-267	13	3	of	of	ADP
egc-267	13	4	these	these	DET
egc-267	13	5	overlapping	overlap	VERB
egc-267	13	6	syndromes	syndrome	NOUN
egc-267	13	7	is	be	AUX
egc-267	13	8	crucial	crucial	ADJ
egc-267	13	9	for	for	ADP
egc-267	13	10	global	global	ADJ
egc-267	13	11	health	health	NOUN
egc-267	13	12	strategies	strategy	NOUN
egc-267	13	13	to	to	PART
egc-267	13	14	mitigate	mitigate	VERB
egc-267	13	15	their	their	PRON
egc-267	13	16	societal	societal	ADJ
egc-267	13	17	and	and	CCONJ
egc-267	13	18	economic	economic	ADJ
egc-267	13	19	impacts	impact	NOUN
egc-267	13	20	.	.	PUNCT
egc-267	14	1	keywords	keyword	NOUN
egc-267	14	2	:	:	PUNCT
egc-267	14	3	cfs	cf	NOUN
egc-267	14	4	;	;	PUNCT
egc-267	14	5	long	long	ADJ
egc-267	14	6	covid	covid	PROPN
egc-267	14	7	;	;	PUNCT
egc-267	14	8	global	global	ADJ
egc-267	14	9	prevalence	prevalence	NOUN
egc-267	14	10	of	of	ADP
egc-267	14	11	long	long	ADJ
egc-267	14	12	covid	covid	PROPN
egc-267	14	13	.	.	PUNCT
egc-267	15	1	introduction	introduction	NOUN
egc-267	15	2	coronavirus	coronavirus	NOUN
egc-267	15	3	disease	disease	NOUN
egc-267	15	4	2019	2019	NUM
egc-267	15	5	(	(	PUNCT
egc-267	15	6	covid-19	covid-19	PROPN
egc-267	15	7	)	)	PUNCT
egc-267	15	8	is	be	AUX
egc-267	15	9	a	a	DET
egc-267	15	10	highly	highly	ADV
egc-267	15	11	contagious	contagious	ADJ
egc-267	15	12	respiratory	respiratory	ADJ
egc-267	15	13	illness	illness	NOUN
egc-267	15	14	caused	cause	VERB
egc-267	15	15	by	by	ADP
egc-267	15	16	the	the	DET
egc-267	15	17	severe	severe	ADJ
egc-267	15	18	acute	acute	ADJ
egc-267	15	19	respiratory	respiratory	ADJ
egc-267	15	20	syndrome	syndrome	NOUN
egc-267	15	21	coronavirus	coronavirus	NOUN
egc-267	15	22	2	2	NUM
egc-267	15	23	(	(	PUNCT
egc-267	15	24	sars	sar	NOUN
egc-267	15	25	-	-	PUNCT
egc-267	15	26	cov-2	cov-2	NOUN
egc-267	15	27	)	)	PUNCT
egc-267	15	28	.	.	PUNCT
egc-267	16	1	prolonged	prolonged	ADJ
egc-267	16	2	recovery	recovery	NOUN
egc-267	16	3	,	,	PUNCT
egc-267	16	4	commonly	commonly	ADV
egc-267	16	5	referred	refer	VERB
egc-267	16	6	to	to	ADP
egc-267	16	7	as	as	ADP
egc-267	16	8	long	long	ADJ
egc-267	16	9	covid-19	covid-19	PROPN
egc-267	16	10	,	,	PUNCT
egc-267	16	11	has	have	AUX
egc-267	16	12	been	be	AUX
egc-267	16	13	observed	observe	VERB
egc-267	16	14	even	even	ADV
egc-267	16	15	in	in	ADP
egc-267	16	16	individuals	individual	NOUN
egc-267	16	17	who	who	PRON
egc-267	16	18	experienced	experience	VERB
egc-267	16	19	mild	mild	ADJ
egc-267	16	20	symptoms	symptom	NOUN
egc-267	16	21	and	and	CCONJ
egc-267	16	22	did	do	AUX
egc-267	16	23	not	not	PART
egc-267	16	24	require	require	VERB
egc-267	16	25	hospitalization	hospitalization	NOUN
egc-267	16	26	.	.	PUNCT
egc-267	17	1	studies	study	NOUN
egc-267	17	2	indicate	indicate	VERB
egc-267	17	3	that	that	SCONJ
egc-267	17	4	at	at	ADV
egc-267	17	5	least	least	ADV
egc-267	17	6	one	one	NUM
egc-267	17	7	in	in	ADP
egc-267	17	8	ten	ten	NUM
egc-267	17	9	symptomatic	symptomatic	ADJ
egc-267	17	10	covid-19	covid-19	PROPN
egc-267	17	11	patients	patient	NOUN
egc-267	17	12	develop	develop	VERB
egc-267	17	13	long	long	ADJ
egc-267	17	14	covid-19	covid-19	PROPN
egc-267	17	15	.	.	PUNCT
egc-267	18	1	although	although	SCONJ
egc-267	18	2	there	there	PRON
egc-267	18	3	are	be	VERB
egc-267	18	4	no	no	DET
egc-267	18	5	evidence	evidence	NOUN
egc-267	18	6	-	-	PUNCT
egc-267	18	7	based	base	VERB
egc-267	18	8	clinical	clinical	ADJ
egc-267	18	9	guidelines	guideline	NOUN
egc-267	18	10	or	or	CCONJ
egc-267	18	11	a	a	DET
egc-267	18	12	clear	clear	ADJ
egc-267	18	13	understanding	understanding	NOUN
egc-267	18	14	of	of	ADP
egc-267	18	15	its	its	PRON
egc-267	18	16	aetiology	aetiology	NOUN
egc-267	18	17	,	,	PUNCT
egc-267	18	18	the	the	DET
egc-267	18	19	international	international	ADJ
egc-267	18	20	severe	severe	ADJ
egc-267	18	21	acute	acute	NOUN
egc-267	18	22	respiratory	respiratory	NOUN
egc-267	18	23	and	and	CCONJ
egc-267	18	24	emerging	emerge	VERB
egc-267	18	25	infection	infection	NOUN
egc-267	18	26	consortium	consortium	NOUN
egc-267	18	27	(	(	PUNCT
egc-267	18	28	isaric	isaric	NOUN
egc-267	18	29	)	)	PUNCT
egc-267	18	30	and	and	CCONJ
egc-267	18	31	the	the	DET
egc-267	18	32	world	world	PROPN
egc-267	18	33	health	health	NOUN
egc-267	18	34	organization	organization	NOUN
egc-267	18	35	(	(	PUNCT
egc-267	18	36	who	who	PRON
egc-267	18	37	)	)	PUNCT
egc-267	18	38	have	have	AUX
egc-267	18	39	proposed	propose	VERB
egc-267	18	40	a	a	DET
egc-267	18	41	clinical	clinical	ADJ
egc-267	18	42	definition	definition	NOUN
egc-267	18	43	for	for	ADP
egc-267	18	44	post	post	ADJ
egc-267	18	45	-	-	ADJ
egc-267	18	46	covid19	covid19	ADJ
egc-267	18	47	conditions	condition	NOUN
egc-267	18	48	.	.	PUNCT
egc-267	19	1	long	long	ADJ
egc-267	19	2	covid-19	covid-19	PROPN
egc-267	19	3	is	be	AUX
egc-267	19	4	characterized	characterize	VERB
egc-267	19	5	by	by	ADP
egc-267	19	6	a	a	DET
egc-267	19	7	history	history	NOUN
egc-267	19	8	of	of	ADP
egc-267	19	9	probable	probable	ADJ
egc-267	19	10	or	or	CCONJ
egc-267	19	11	confirmed	confirm	VERB
egc-267	19	12	sars	sar	NOUN
egc-267	19	13	-	-	PUNCT
egc-267	19	14	cov-2	cov-2	PART
egc-267	19	15	infection	infection	NOUN
egc-267	19	16	,	,	PUNCT
egc-267	19	17	typically	typically	ADV
egc-267	19	18	manifesting	manifest	VERB
egc-267	19	19	three	three	NUM
egc-267	19	20	months	month	NOUN
egc-267	19	21	after	after	ADP
egc-267	19	22	the	the	DET
egc-267	19	23	onset	onset	NOUN
egc-267	19	24	of	of	ADP
egc-267	19	25	covid-19	covid-19	PROPN
egc-267	19	26	,	,	PUNCT
egc-267	19	27	with	with	ADP
egc-267	19	28	symptoms	symptom	NOUN
egc-267	19	29	lasting	last	VERB
egc-267	19	30	at	at	ADP
egc-267	19	31	least	least	ADV
egc-267	19	32	two	two	NUM
egc-267	19	33	months	month	NOUN
egc-267	19	34	and	and	CCONJ
egc-267	19	35	not	not	PART
egc-267	19	36	attributable	attributable	ADJ
egc-267	19	37	to	to	ADP
egc-267	19	38	another	another	DET
egc-267	19	39	diagnosis	diagnosis	NOUN
egc-267	19	40	.	.	PUNCT
egc-267	20	1	patients	patient	NOUN
egc-267	20	2	often	often	ADV
egc-267	20	3	exhibit	exhibit	VERB
egc-267	20	4	a	a	DET
egc-267	20	5	wide	wide	ADJ
egc-267	20	6	range	range	NOUN
egc-267	20	7	of	of	ADP
egc-267	20	8	nonspecific	nonspecific	ADJ
egc-267	20	9	symptoms	symptom	NOUN
egc-267	20	10	that	that	PRON
egc-267	20	11	can	can	AUX
egc-267	20	12	fluctuate	fluctuate	VERB
egc-267	20	13	or	or	CCONJ
egc-267	20	14	recur	recur	VERB
egc-267	20	15	over	over	ADP
egc-267	20	16	time	time	NOUN
egc-267	20	17	.	.	PUNCT
egc-267	21	1	commonly	commonly	ADV
egc-267	21	2	reported	report	VERB
egc-267	21	3	symptoms	symptom	NOUN
egc-267	21	4	include	include	VERB
egc-267	21	5	fatigue	fatigue	NOUN
egc-267	21	6	,	,	PUNCT
egc-267	21	7	pain	pain	NOUN
egc-267	21	8	,	,	PUNCT
egc-267	21	9	dyspnea	dyspnea	NOUN
egc-267	21	10	,	,	PUNCT
egc-267	21	11	sleep	sleep	NOUN
egc-267	21	12	disturbances	disturbance	NOUN
egc-267	21	13	,	,	PUNCT
egc-267	21	14	physical	physical	ADJ
egc-267	21	15	sequelae	sequelae	NOUN
egc-267	21	16	,	,	PUNCT
egc-267	21	17	psychological	psychological	ADJ
egc-267	21	18	distress	distress	NOUN
egc-267	21	19	,	,	PUNCT
egc-267	21	20	and	and	CCONJ
egc-267	21	21	cognitive	cognitive	ADJ
egc-267	21	22	impairment	impairment	NOUN
egc-267	21	23	,	,	PUNCT
egc-267	21	24	all	all	PRON
egc-267	21	25	of	of	ADP
egc-267	21	26	which	which	PRON
egc-267	21	27	significantly	significantly	ADV
egc-267	21	28	impact	impact	VERB
egc-267	21	29	quality	quality	NOUN
egc-267	21	30	of	of	ADP
egc-267	21	31	life	life	NOUN
egc-267	21	32	.	.	PUNCT
egc-267	22	1	symptoms	symptom	NOUN
egc-267	22	2	may	may	AUX
egc-267	22	3	persist	persist	VERB
egc-267	22	4	from	from	ADP
egc-267	22	5	the	the	DET
egc-267	22	6	initial	initial	ADJ
egc-267	22	7	illness	illness	NOUN
egc-267	22	8	or	or	CCONJ
egc-267	22	9	appear	appear	VERB
egc-267	22	10	anew	anew	ADV
egc-267	22	11	after	after	ADP
egc-267	22	12	recovery	recovery	NOUN
egc-267	22	13	from	from	ADP
egc-267	22	14	the	the	DET
egc-267	22	15	acute	acute	ADJ
egc-267	22	16	phase	phase	NOUN
egc-267	22	17	of	of	ADP
egc-267	22	18	covid-19	covid-19	PROPN
egc-267	22	19	.	.	PUNCT
egc-267	23	1	these	these	DET
egc-267	23	2	manifestations	manifestation	NOUN
egc-267	23	3	can	can	AUX
egc-267	23	4	resemble	resemble	VERB
egc-267	23	5	those	those	PRON
egc-267	23	6	seen	see	VERB
egc-267	23	7	in	in	ADP
egc-267	23	8	myalgic	myalgic	ADJ
egc-267	23	9	encephalomyelitis	encephalomyelitis	NOUN
egc-267	23	10	/	/	SYM
egc-267	23	11	chronic	chronic	ADJ
egc-267	23	12	fatigue	fatigue	NOUN
egc-267	23	13	syndrome	syndrome	NOUN
egc-267	23	14	(	(	PUNCT
egc-267	23	15	me	i	PRON
egc-267	23	16	/	/	SYM
egc-267	23	17	cfs	cfs	PROPN
egc-267	23	18	)	)	PUNCT
egc-267	23	19	.	.	PUNCT
egc-267	24	1	[	[	X
egc-267	24	2	1	1	X
egc-267	24	3	]	]	PUNCT
egc-267	24	4	methodology	methodology	NOUN
egc-267	24	5	exploring	explore	VERB
egc-267	24	6	the	the	DET
egc-267	24	7	potential	potential	ADJ
egc-267	24	8	connection	connection	NOUN
egc-267	24	9	between	between	ADP
egc-267	24	10	me	i	PRON
egc-267	24	11	/	/	SYM
egc-267	24	12	cfs	cfs	PROPN
egc-267	24	13	and	and	CCONJ
egc-267	24	14	long	long	ADJ
egc-267	24	15	covid-19	covid-19	PROPN
egc-267	24	16	is	be	AUX
egc-267	24	17	complicated	complicate	VERB
egc-267	24	18	by	by	ADP
egc-267	24	19	the	the	DET
egc-267	24	20	significant	significant	ADJ
egc-267	24	21	heterogeneity	heterogeneity	NOUN
egc-267	24	22	in	in	ADP
egc-267	24	23	clinical	clinical	ADJ
egc-267	24	24	presentation	presentation	NOUN
egc-267	24	25	and	and	CCONJ
egc-267	24	26	the	the	DET
egc-267	24	27	lack	lack	NOUN
egc-267	24	28	of	of	ADP
egc-267	24	29	sensitive	sensitive	ADJ
egc-267	24	30	screening	screening	NOUN
egc-267	24	31	tools	tool	NOUN
egc-267	24	32	and	and	CCONJ
egc-267	24	33	standardized	standardize	VERB
egc-267	24	34	diagnostic	diagnostic	ADJ
egc-267	24	35	criteria	criterion	NOUN
egc-267	24	36	.	.	PUNCT
egc-267	25	1	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	ADJ
egc-267	25	2	eglobal	eglobal	PROPN
egc-267	25	3	congress	congress	PROPN
egc-267	25	4	hosted	host	VERB
egc-267	25	5	online	online	ADV
egc-267	25	6	from	from	ADP
egc-267	25	7	dubai	dubai	PROPN
egc-267	25	8	,	,	PUNCT
egc-267	25	9	u.	u.	PROPN
egc-267	25	10	a.	a.	PROPN
egc-267	25	11	e.	e.	PROPN
egc-267	25	12	,	,	PUNCT
egc-267	25	13	e	e	PROPN
egc-267	25	14	conference	conference	NOUN
egc-267	25	15	.	.	PUNCT
egc-267	26	1	date	date	NOUN
egc-267	26	2	:	:	PUNCT
egc-267	26	3	29th	29th	ADJ
egc-267	26	4	october	october	PROPN
egc-267	26	5	2024	2024	NUM
egc-267	26	6	website	website	NOUN
egc-267	26	7	:	:	PUNCT
egc-267	26	8	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-267	26	9	issn	issn	PROPN
egc-267	26	10	(	(	PUNCT
egc-267	26	11	e	e	NOUN
egc-267	26	12	):	):	PUNCT
egc-267	26	13	2836	2836	NUM
egc-267	26	14	-	-	SYM
egc-267	26	15	3612	3612	NUM
egc-267	26	16	76	76	NUM
egc-267	27	1	|	|	ADV
egc-267	27	2	p	p	NOUN
egc-267	27	3	a	a	DET
egc-267	27	4	g	g	NOUN
egc-267	27	5	e	e	NOUN
egc-267	27	6	based	base	VERB
egc-267	27	7	on	on	ADP
egc-267	27	8	the	the	DET
egc-267	27	9	hypothesis	hypothesis	NOUN
egc-267	27	10	that	that	PRON
egc-267	27	11	post	post	ADJ
egc-267	27	12	-	-	ADJ
egc-267	27	13	covid-19	covid-19	ADJ
egc-267	27	14	patients	patient	NOUN
egc-267	27	15	may	may	AUX
egc-267	27	16	develop	develop	VERB
egc-267	27	17	a	a	DET
egc-267	27	18	postviral	postviral	ADJ
egc-267	27	19	fatigue	fatigue	NOUN
egc-267	27	20	syndrome	syndrome	NOUN
egc-267	27	21	closely	closely	ADV
egc-267	27	22	resembling	resemble	VERB
egc-267	27	23	me	i	PRON
egc-267	27	24	/	/	SYM
egc-267	27	25	cfs	cfs	PROPN
egc-267	27	26	,	,	PUNCT
egc-267	27	27	the	the	DET
egc-267	27	28	researches	research	NOUN
egc-267	27	29	propose	propose	VERB
egc-267	27	30	subgrouping	subgroupe	VERB
egc-267	27	31	individuals	individual	NOUN
egc-267	27	32	with	with	ADP
egc-267	27	33	long	long	ADJ
egc-267	27	34	covid-19	covid-19	PROPN
egc-267	27	35	into	into	ADP
egc-267	27	36	two	two	NUM
egc-267	27	37	distinct	distinct	ADJ
egc-267	27	38	clinical	clinical	ADJ
egc-267	27	39	phenotypes	phenotype	NOUN
egc-267	27	40	.	.	PUNCT
egc-267	28	1	the	the	DET
egc-267	28	2	first	first	ADJ
egc-267	28	3	cluster	cluster	NOUN
egc-267	28	4	consists	consist	VERB
egc-267	28	5	of	of	ADP
egc-267	28	6	patients	patient	NOUN
egc-267	28	7	who	who	PRON
egc-267	28	8	experienced	experience	VERB
egc-267	28	9	mild	mild	ADJ
egc-267	28	10	covid-19	covid-19	PROPN
egc-267	28	11	symptoms	symptom	NOUN
egc-267	28	12	and	and	CCONJ
egc-267	28	13	did	do	AUX
egc-267	28	14	not	not	PART
egc-267	28	15	require	require	VERB
egc-267	28	16	hospitalization	hospitalization	NOUN
egc-267	28	17	(	(	PUNCT
egc-267	28	18	outpatient	outpatient	NOUN
egc-267	28	19	care	care	NOUN
egc-267	28	20	)	)	PUNCT
egc-267	28	21	but	but	CCONJ
egc-267	28	22	developed	develop	VERB
egc-267	28	23	persistent	persistent	ADJ
egc-267	28	24	symptoms	symptom	NOUN
egc-267	28	25	after	after	ADP
egc-267	28	26	the	the	DET
egc-267	28	27	acute	acute	NOUN
egc-267	28	28	phase	phase	NOUN
egc-267	28	29	,	,	PUNCT
egc-267	28	30	referred	refer	VERB
egc-267	28	31	to	to	ADP
egc-267	28	32	as	as	ADP
egc-267	28	33	post	post	ADJ
egc-267	28	34	-	-	ADJ
egc-267	28	35	covid-19	covid-19	ADJ
egc-267	28	36	fatigue	fatigue	NOUN
egc-267	28	37	syndrome	syndrome	NOUN
egc-267	28	38	(	(	PUNCT
egc-267	28	39	pcfs	pcfs	PROPN
egc-267	28	40	)	)	PUNCT
egc-267	28	41	.	.	PUNCT
egc-267	29	1	there	there	PRON
egc-267	29	2	may	may	AUX
egc-267	29	3	be	be	AUX
egc-267	29	4	many	many	ADJ
egc-267	29	5	clinical	clinical	ADJ
egc-267	29	6	similarities	similarity	NOUN
egc-267	29	7	and	and	CCONJ
egc-267	29	8	shared	share	VERB
egc-267	29	9	pathophysiological	pathophysiological	ADJ
egc-267	29	10	features	feature	NOUN
egc-267	29	11	between	between	ADP
egc-267	29	12	patients	patient	NOUN
egc-267	29	13	with	with	ADP
egc-267	29	14	me	i	PRON
egc-267	29	15	/	/	SYM
egc-267	29	16	cfs	cfs	PROPN
egc-267	29	17	and	and	CCONJ
egc-267	29	18	those	those	PRON
egc-267	29	19	with	with	ADP
egc-267	29	20	pcfs	pcfs	PROPN
egc-267	29	21	(	(	PUNCT
egc-267	29	22	me	i	PRON
egc-267	29	23	/	/	SYM
egc-267	29	24	cfs	cfs	NOUN
egc-267	29	25	-	-	PUNCT
egc-267	29	26	like	like	ADJ
egc-267	29	27	)	)	PUNCT
egc-267	29	28	.	.	PUNCT
egc-267	30	1	the	the	DET
egc-267	30	2	second	second	ADJ
egc-267	30	3	cluster	cluster	NOUN
egc-267	30	4	includes	include	VERB
egc-267	30	5	patients	patient	NOUN
egc-267	30	6	who	who	PRON
egc-267	30	7	required	require	VERB
egc-267	30	8	hospitalization	hospitalization	NOUN
egc-267	30	9	for	for	ADP
egc-267	30	10	severe	severe	ADJ
egc-267	30	11	covid-19	covid-19	PROPN
egc-267	30	12	(	(	PUNCT
egc-267	30	13	either	either	CCONJ
egc-267	30	14	in	in	ADP
egc-267	30	15	the	the	DET
egc-267	30	16	icu	icu	PROPN
egc-267	30	17	or	or	CCONJ
egc-267	30	18	a	a	DET
egc-267	30	19	non	non	ADJ
egc-267	30	20	-	-	ADJ
egc-267	30	21	icu	icu	ADJ
egc-267	30	22	ward	ward	NOUN
egc-267	30	23	)	)	PUNCT
egc-267	30	24	and	and	CCONJ
egc-267	30	25	subsequently	subsequently	ADV
egc-267	30	26	developed	develop	VERB
egc-267	30	27	persistent	persistent	ADJ
egc-267	30	28	symptoms	symptom	NOUN
egc-267	30	29	after	after	ADP
egc-267	30	30	discharge	discharge	NOUN
egc-267	30	31	,	,	PUNCT
egc-267	30	32	termed	term	VERB
egc-267	30	33	post	post	ADJ
egc-267	30	34	-	-	ADJ
egc-267	30	35	acute	acute	ADJ
egc-267	30	36	covid19	covid19	NOUN
egc-267	30	37	syndrome	syndrome	NOUN
egc-267	30	38	(	(	PUNCT
egc-267	30	39	pacs	pac	NOUN
egc-267	30	40	)	)	PUNCT
egc-267	30	41	.	.	PUNCT
egc-267	31	1	it	it	PRON
egc-267	31	2	is	be	AUX
egc-267	31	3	important	important	ADJ
egc-267	31	4	to	to	PART
egc-267	31	5	differentiate	differentiate	VERB
egc-267	31	6	icu	icu	PROPN
egc-267	31	7	-	-	PUNCT
egc-267	31	8	pacs	pac	NOUN
egc-267	31	9	patients	patient	NOUN
egc-267	31	10	from	from	ADP
egc-267	31	11	those	those	PRON
egc-267	31	12	experiencing	experience	VERB
egc-267	31	13	post	post	ADJ
egc-267	31	14	-	-	ADJ
egc-267	31	15	intensive	intensive	ADJ
egc-267	31	16	care	care	NOUN
egc-267	31	17	syndrome	syndrome	NOUN
egc-267	31	18	(	(	PUNCT
egc-267	31	19	pics	pic	NOUN
egc-267	31	20	)	)	PUNCT
egc-267	31	21	,	,	PUNCT
egc-267	31	22	which	which	PRON
egc-267	31	23	is	be	AUX
egc-267	31	24	defined	define	VERB
egc-267	31	25	as	as	ADP
egc-267	31	26	"	"	PUNCT
egc-267	31	27	new	new	ADJ
egc-267	31	28	or	or	CCONJ
egc-267	31	29	worsening	worsen	VERB
egc-267	31	30	impairment	impairment	NOUN
egc-267	31	31	of	of	ADP
egc-267	31	32	cognition	cognition	NOUN
egc-267	31	33	,	,	PUNCT
egc-267	31	34	mental	mental	ADJ
egc-267	31	35	health	health	NOUN
egc-267	31	36	,	,	PUNCT
egc-267	31	37	or	or	CCONJ
egc-267	31	38	physical	physical	ADJ
egc-267	31	39	function	function	NOUN
egc-267	31	40	following	follow	VERB
egc-267	31	41	critical	critical	ADJ
egc-267	31	42	illness	illness	NOUN
egc-267	31	43	,	,	PUNCT
egc-267	31	44	lasting	last	VERB
egc-267	31	45	beyond	beyond	ADP
egc-267	31	46	the	the	DET
egc-267	31	47	acute	acute	ADJ
egc-267	31	48	hospital	hospital	NOUN
egc-267	31	49	stay	stay	NOUN
egc-267	31	50	.	.	PUNCT
egc-267	31	51	"	"	PUNCT
egc-267	32	1	although	although	SCONJ
egc-267	32	2	there	there	PRON
egc-267	32	3	are	be	VERB
egc-267	32	4	some	some	DET
egc-267	32	5	differences	difference	NOUN
egc-267	32	6	between	between	ADP
egc-267	32	7	icu	icu	PROPN
egc-267	32	8	-	-	PUNCT
egc-267	32	9	pacs	pac	NOUN
egc-267	32	10	and	and	CCONJ
egc-267	32	11	pics	pic	NOUN
egc-267	32	12	—	—	PUNCT
egc-267	32	13	likely	likely	ADV
egc-267	32	14	reflecting	reflect	VERB
egc-267	32	15	the	the	DET
egc-267	32	16	varied	varied	ADJ
egc-267	32	17	impacts	impact	NOUN
egc-267	32	18	of	of	ADP
egc-267	32	19	critical	critical	ADJ
egc-267	32	20	illness	illness	NOUN
egc-267	32	21	—	—	PUNCT
egc-267	32	22	the	the	DET
egc-267	32	23	symptoms	symptom	NOUN
egc-267	32	24	of	of	ADP
egc-267	32	25	both	both	DET
egc-267	32	26	conditions	condition	NOUN
egc-267	32	27	may	may	AUX
egc-267	32	28	share	share	VERB
egc-267	32	29	underlying	underlie	VERB
egc-267	32	30	factors	factor	NOUN
egc-267	32	31	such	such	ADJ
egc-267	32	32	as	as	ADP
egc-267	32	33	immune	immune	ADJ
egc-267	32	34	alterations	alteration	NOUN
egc-267	32	35	,	,	PUNCT
egc-267	32	36	neurological	neurological	ADJ
egc-267	32	37	involvement	involvement	NOUN
egc-267	32	38	,	,	PUNCT
egc-267	32	39	adverse	adverse	ADJ
egc-267	32	40	effects	effect	NOUN
egc-267	32	41	of	of	ADP
egc-267	32	42	treatment	treatment	NOUN
egc-267	32	43	,	,	PUNCT
egc-267	32	44	prolonged	prolonged	ADJ
egc-267	32	45	immobilization	immobilization	NOUN
egc-267	32	46	,	,	PUNCT
egc-267	32	47	and	and	CCONJ
egc-267	32	48	mitochondrial	mitochondrial	ADJ
egc-267	32	49	dysfunction	dysfunction	NOUN
egc-267	32	50	.	.	PUNCT
egc-267	33	1	given	give	VERB
egc-267	33	2	the	the	DET
egc-267	33	3	strong	strong	ADJ
egc-267	33	4	evidence	evidence	NOUN
egc-267	33	5	supporting	support	VERB
egc-267	33	6	multidisciplinary	multidisciplinary	ADJ
egc-267	33	7	treatment	treatment	NOUN
egc-267	33	8	programs	program	NOUN
egc-267	33	9	for	for	ADP
egc-267	33	10	me	i	PRON
egc-267	33	11	/	/	SYM
egc-267	33	12	cfs	cfs	PROPN
egc-267	33	13	,	,	PUNCT
egc-267	33	14	which	which	PRON
egc-267	33	15	combine	combine	VERB
egc-267	33	16	pharmacological	pharmacological	ADJ
egc-267	33	17	approaches	approach	NOUN
egc-267	33	18	tailored	tailor	VERB
egc-267	33	19	to	to	ADP
egc-267	33	20	symptoms	symptom	NOUN
egc-267	33	21	,	,	PUNCT
egc-267	33	22	education	education	NOUN
egc-267	33	23	,	,	PUNCT
egc-267	33	24	physical	physical	ADJ
egc-267	33	25	exercise	exercise	NOUN
egc-267	33	26	,	,	PUNCT
egc-267	33	27	and	and	CCONJ
egc-267	33	28	cognitive	cognitive	ADJ
egc-267	33	29	behavioral	behavioral	ADJ
egc-267	33	30	therapy	therapy	NOUN
egc-267	33	31	,	,	PUNCT
egc-267	33	32	we	we	PRON
egc-267	33	33	believe	believe	VERB
egc-267	33	34	that	that	SCONJ
egc-267	33	35	implementing	implement	VERB
egc-267	33	36	a	a	DET
egc-267	33	37	similar	similar	ADJ
egc-267	33	38	follow	follow	NOUN
egc-267	33	39	-	-	PUNCT
egc-267	33	40	up	up	ADP
egc-267	33	41	program	program	NOUN
egc-267	33	42	could	could	AUX
egc-267	33	43	be	be	AUX
egc-267	33	44	beneficial	beneficial	ADJ
egc-267	33	45	for	for	ADP
egc-267	33	46	patients	patient	NOUN
egc-267	33	47	with	with	ADP
egc-267	33	48	long	long	ADJ
egc-267	33	49	covid-19	covid-19	PROPN
egc-267	33	50	.	.	PUNCT
egc-267	34	1	long	long	PROPN
egc-267	34	2	covid-19	covid-19	PROPN
egc-267	34	3	should	should	AUX
egc-267	34	4	be	be	AUX
egc-267	34	5	treated	treat	VERB
egc-267	34	6	as	as	ADP
egc-267	34	7	a	a	DET
egc-267	34	8	public	public	ADJ
egc-267	34	9	health	health	NOUN
egc-267	34	10	emergency	emergency	NOUN
egc-267	34	11	.	.	PUNCT
egc-267	35	1	further	far	ADV
egc-267	35	2	well	well	ADV
egc-267	35	3	-	-	PUNCT
egc-267	35	4	conducted	conduct	VERB
egc-267	35	5	studies	study	NOUN
egc-267	35	6	are	be	AUX
egc-267	35	7	essential	essential	ADJ
egc-267	35	8	to	to	PART
egc-267	35	9	determine	determine	VERB
egc-267	35	10	the	the	DET
egc-267	35	11	true	true	ADJ
egc-267	35	12	prevalence	prevalence	NOUN
egc-267	35	13	,	,	PUNCT
egc-267	35	14	phenotypes	phenotype	NOUN
egc-267	35	15	,	,	PUNCT
egc-267	35	16	risk	risk	NOUN
egc-267	35	17	factors	factor	NOUN
egc-267	35	18	,	,	PUNCT
egc-267	35	19	potential	potential	ADJ
egc-267	35	20	treatments	treatment	NOUN
egc-267	35	21	,	,	PUNCT
egc-267	35	22	and	and	CCONJ
egc-267	35	23	the	the	DET
egc-267	35	24	differences	difference	NOUN
egc-267	35	25	between	between	ADP
egc-267	35	26	long	long	ADJ
egc-267	35	27	covid-19	covid-19	PROPN
egc-267	35	28	and	and	CCONJ
egc-267	35	29	me	i	PRON
egc-267	35	30	/	/	SYM
egc-267	35	31	cfs	cfs	PROPN
egc-267	35	32	,	,	PUNCT
egc-267	35	33	as	as	ADV
egc-267	35	34	well	well	ADV
egc-267	35	35	as	as	ADP
egc-267	35	36	other	other	ADJ
egc-267	35	37	overlapping	overlap	VERB
egc-267	35	38	conditions	condition	NOUN
egc-267	35	39	like	like	ADP
egc-267	35	40	pics	pic	NOUN
egc-267	35	41	.	.	PUNCT
egc-267	36	1	[	[	X
egc-267	36	2	3	3	NUM
egc-267	36	3	]	]	PUNCT
egc-267	36	4	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-267	36	5	eglobal	eglobal	PROPN
egc-267	36	6	congress	congress	PROPN
egc-267	36	7	hosted	host	VERB
egc-267	36	8	online	online	ADV
egc-267	36	9	from	from	ADP
egc-267	36	10	dubai	dubai	PROPN
egc-267	36	11	,	,	PUNCT
egc-267	36	12	u.	u.	PROPN
egc-267	36	13	a.	a.	PROPN
egc-267	36	14	e.	e.	PROPN
egc-267	36	15	,	,	PUNCT
egc-267	36	16	e	e	PROPN
egc-267	36	17	conference	conference	NOUN
egc-267	36	18	.	.	PUNCT
egc-267	37	1	date	date	NOUN
egc-267	37	2	:	:	PUNCT
egc-267	37	3	29th	29th	ADJ
egc-267	37	4	october	october	PROPN
egc-267	37	5	2024	2024	NUM
egc-267	37	6	website	website	NOUN
egc-267	37	7	:	:	PUNCT
egc-267	37	8	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-267	37	9	issn	issn	PROPN
egc-267	37	10	(	(	PUNCT
egc-267	37	11	e	e	NOUN
egc-267	37	12	):	):	PUNCT
egc-267	37	13	2836	2836	NUM
egc-267	37	14	-	-	SYM
egc-267	37	15	3612	3612	NUM
egc-267	37	16	77	77	NUM
egc-267	38	1	|	|	ADV
egc-267	38	2	p	p	NOUN
egc-267	38	3	a	a	DET
egc-267	38	4	g	g	NOUN
egc-267	38	5	e	e	NOUN
egc-267	38	6	discussion	discussion	NOUN
egc-267	38	7	me	i	PRON
egc-267	38	8	/	/	SYM
egc-267	38	9	cfs	cfs	PROPN
egc-267	38	10	is	be	AUX
egc-267	38	11	a	a	DET
egc-267	38	12	complex	complex	ADJ
egc-267	38	13	,	,	PUNCT
egc-267	38	14	long	long	ADJ
egc-267	38	15	-	-	PUNCT
egc-267	38	16	term	term	NOUN
egc-267	38	17	,	,	PUNCT
egc-267	38	18	multisystem	multisystem	NOUN
egc-267	38	19	disorder	disorder	NOUN
egc-267	38	20	first	first	ADV
egc-267	38	21	defined	define	VERB
egc-267	38	22	in	in	ADP
egc-267	38	23	1988	1988	NUM
egc-267	38	24	by	by	ADP
egc-267	38	25	holmes	holmes	PROPN
egc-267	38	26	et	et	PROPN
egc-267	38	27	al	al	PROPN
egc-267	38	28	.	.	PROPN
egc-267	39	1	as	as	ADP
egc-267	39	2	a	a	DET
egc-267	39	3	post	post	ADJ
egc-267	39	4	-	-	ADJ
egc-267	39	5	viral	viral	ADJ
egc-267	39	6	fatigue	fatigue	NOUN
egc-267	39	7	syndrome	syndrome	NOUN
egc-267	39	8	.	.	PUNCT
egc-267	40	1	diagnosis	diagnosis	NOUN
egc-267	40	2	can	can	AUX
egc-267	40	3	be	be	AUX
egc-267	40	4	made	make	VERB
egc-267	40	5	using	use	VERB
egc-267	40	6	the	the	DET
egc-267	40	7	1994	1994	NUM
egc-267	40	8	fukuda	fukuda	NOUN
egc-267	40	9	criteria	criterion	NOUN
egc-267	40	10	,	,	PUNCT
egc-267	40	11	the	the	DET
egc-267	40	12	canadian	canadian	ADJ
egc-267	40	13	consensus	consensus	NOUN
egc-267	40	14	document	document	NOUN
egc-267	40	15	from	from	ADP
egc-267	40	16	2003	2003	NUM
egc-267	40	17	,	,	PUNCT
egc-267	40	18	or	or	CCONJ
egc-267	40	19	the	the	DET
egc-267	40	20	more	more	ADV
egc-267	40	21	recent	recent	ADJ
egc-267	40	22	international	international	ADJ
egc-267	40	23	consensus	consensus	NOUN
egc-267	40	24	criteria	criterion	NOUN
egc-267	40	25	from	from	ADP
egc-267	40	26	2011	2011	NUM
egc-267	40	27	,	,	PUNCT
egc-267	40	28	which	which	PRON
egc-267	40	29	detail	detail	VERB
egc-267	40	30	its	its	PRON
egc-267	40	31	pathophysiology	pathophysiology	NOUN
egc-267	40	32	,	,	PUNCT
egc-267	40	33	symptoms	symptom	NOUN
egc-267	40	34	,	,	PUNCT
egc-267	40	35	and	and	CCONJ
egc-267	40	36	treatment	treatment	NOUN
egc-267	40	37	.	.	PUNCT
egc-267	41	1	the	the	DET
egc-267	41	2	disorder	disorder	NOUN
egc-267	41	3	is	be	AUX
egc-267	41	4	marked	mark	VERB
egc-267	41	5	by	by	ADP
egc-267	41	6	prolonged	prolonged	ADJ
egc-267	41	7	and	and	CCONJ
egc-267	41	8	abnormal	abnormal	ADJ
egc-267	41	9	fatigue	fatigue	NOUN
egc-267	41	10	after	after	ADP
egc-267	41	11	exertion	exertion	NOUN
egc-267	41	12	,	,	PUNCT
egc-267	41	13	which	which	PRON
egc-267	41	14	does	do	AUX
egc-267	41	15	not	not	PART
egc-267	41	16	improve	improve	VERB
egc-267	41	17	significantly	significantly	ADV
egc-267	41	18	with	with	ADP
egc-267	41	19	rest	rest	NOUN
egc-267	41	20	,	,	PUNCT
egc-267	41	21	as	as	ADV
egc-267	41	22	well	well	ADV
egc-267	41	23	as	as	ADP
egc-267	41	24	recurrent	recurrent	ADJ
egc-267	41	25	headaches	headache	NOUN
egc-267	41	26	and	and	CCONJ
egc-267	41	27	concentration	concentration	NOUN
egc-267	41	28	and	and	CCONJ
egc-267	41	29	memory	memory	NOUN
egc-267	41	30	problems	problem	NOUN
egc-267	41	31	that	that	PRON
egc-267	41	32	have	have	AUX
egc-267	41	33	emerged	emerge	VERB
egc-267	41	34	within	within	ADP
egc-267	41	35	the	the	DET
egc-267	41	36	past	past	ADJ
egc-267	41	37	six	six	NUM
egc-267	41	38	months	month	NOUN
egc-267	41	39	.	.	PUNCT
egc-267	42	1	other	other	ADJ
egc-267	42	2	accompanying	accompany	VERB
egc-267	42	3	symptoms	symptom	NOUN
egc-267	42	4	include	include	VERB
egc-267	42	5	tender	tender	NOUN
egc-267	42	6	lymph	lymph	NOUN
egc-267	42	7	nodes	node	NOUN
egc-267	42	8	,	,	PUNCT
egc-267	42	9	musculoskeletal	musculoskeletal	ADJ
egc-267	42	10	pain	pain	NOUN
egc-267	42	11	,	,	PUNCT
egc-267	42	12	sleep	sleep	NOUN
egc-267	42	13	disturbances	disturbance	NOUN
egc-267	42	14	,	,	PUNCT
egc-267	42	15	and	and	CCONJ
egc-267	42	16	psychiatric	psychiatric	ADJ
egc-267	42	17	issues	issue	NOUN
egc-267	42	18	.	.	PUNCT
egc-267	43	1	although	although	SCONJ
egc-267	43	2	the	the	DET
egc-267	43	3	exact	exact	ADJ
egc-267	43	4	cause	cause	NOUN
egc-267	43	5	of	of	ADP
egc-267	43	6	me	i	PRON
egc-267	43	7	/	/	SYM
egc-267	43	8	cfs	cfs	PROPN
egc-267	43	9	remains	remain	VERB
egc-267	43	10	unclear	unclear	ADJ
egc-267	43	11	,	,	PUNCT
egc-267	43	12	ongoing	ongoing	ADJ
egc-267	43	13	research	research	NOUN
egc-267	43	14	is	be	AUX
egc-267	43	15	investigating	investigate	VERB
egc-267	43	16	its	its	PRON
egc-267	43	17	aetiopathogenesis	aetiopathogenesis	NOUN
egc-267	43	18	.	.	PUNCT
egc-267	44	1	known	know	VERB
egc-267	44	2	predisposing	predispose	VERB
egc-267	44	3	factors	factor	NOUN
egc-267	44	4	include	include	VERB
egc-267	44	5	female	female	ADJ
egc-267	44	6	sex	sex	NOUN
egc-267	44	7	,	,	PUNCT
egc-267	44	8	type	type	VERB
egc-267	44	9	a	a	DET
egc-267	44	10	personality	personality	NOUN
egc-267	44	11	,	,	PUNCT
egc-267	44	12	and	and	CCONJ
egc-267	44	13	family	family	NOUN
egc-267	44	14	history	history	NOUN
egc-267	44	15	.	.	PUNCT
egc-267	45	1	various	various	ADJ
egc-267	45	2	infectious	infectious	ADJ
egc-267	45	3	agents	agent	NOUN
egc-267	45	4	(	(	PUNCT
egc-267	45	5	such	such	ADJ
egc-267	45	6	as	as	ADP
egc-267	45	7	those	those	PRON
egc-267	45	8	from	from	ADP
egc-267	45	9	the	the	DET
egc-267	45	10	human	human	ADJ
egc-267	45	11	herpesvirus	herpesvirus	NOUN
egc-267	45	12	family	family	NOUN
egc-267	45	13	)	)	PUNCT
egc-267	45	14	,	,	PUNCT
egc-267	45	15	toxic	toxic	ADJ
egc-267	45	16	exposures	exposure	NOUN
egc-267	45	17	,	,	PUNCT
egc-267	45	18	and	and	CCONJ
egc-267	45	19	psychological	psychological	ADJ
egc-267	45	20	and	and	CCONJ
egc-267	45	21	social	social	ADJ
egc-267	45	22	experiences	experience	NOUN
egc-267	45	23	are	be	AUX
egc-267	45	24	associated	associate	VERB
egc-267	45	25	with	with	ADP
egc-267	45	26	its	its	PRON
egc-267	45	27	onset	onset	NOUN
egc-267	45	28	.	.	PUNCT
egc-267	46	1	factors	factor	NOUN
egc-267	46	2	such	such	ADJ
egc-267	46	3	as	as	ADP
egc-267	46	4	older	old	ADJ
egc-267	46	5	age	age	NOUN
egc-267	46	6	,	,	PUNCT
egc-267	46	7	delays	delay	NOUN
egc-267	46	8	in	in	ADP
egc-267	46	9	diagnosis	diagnosis	NOUN
egc-267	46	10	,	,	PUNCT
egc-267	46	11	severe	severe	ADJ
egc-267	46	12	initial	initial	ADJ
egc-267	46	13	symptoms	symptom	NOUN
egc-267	46	14	,	,	PUNCT
egc-267	46	15	comorbidities	comorbiditie	NOUN
egc-267	46	16	,	,	PUNCT
egc-267	46	17	and	and	CCONJ
egc-267	46	18	adaptive	adaptive	ADJ
egc-267	46	19	disorders	disorder	NOUN
egc-267	46	20	may	may	AUX
egc-267	46	21	contribute	contribute	VERB
egc-267	46	22	to	to	ADP
egc-267	46	23	the	the	DET
egc-267	46	24	persistence	persistence	NOUN
egc-267	46	25	of	of	ADP
egc-267	46	26	the	the	DET
egc-267	46	27	illness	illness	NOUN
egc-267	46	28	.	.	PUNCT
egc-267	47	1	emerging	emerge	VERB
egc-267	47	2	data	datum	NOUN
egc-267	47	3	suggest	suggest	VERB
egc-267	47	4	a	a	DET
egc-267	47	5	link	link	NOUN
egc-267	47	6	between	between	ADP
egc-267	47	7	redox	redox	ADJ
egc-267	47	8	imbalance	imbalance	NOUN
egc-267	47	9	,	,	PUNCT
egc-267	47	10	mitochondrial	mitochondrial	ADJ
egc-267	47	11	dysfunction	dysfunction	NOUN
egc-267	47	12	,	,	PUNCT
egc-267	47	13	and	and	CCONJ
egc-267	47	14	oxidative	oxidative	ADJ
egc-267	47	15	stress	stress	NOUN
egc-267	47	16	pathways	pathway	NOUN
egc-267	47	17	in	in	ADP
egc-267	47	18	me	i	PRON
egc-267	47	19	/	/	SYM
egc-267	47	20	cfs	cfs	NOUN
egc-267	47	21	patients	patient	NOUN
egc-267	47	22	,	,	PUNCT
egc-267	47	23	which	which	PRON
egc-267	47	24	have	have	AUX
egc-267	47	25	also	also	ADV
egc-267	47	26	been	be	AUX
egc-267	47	27	observed	observe	VERB
egc-267	47	28	in	in	ADP
egc-267	47	29	individuals	individual	NOUN
egc-267	47	30	with	with	ADP
egc-267	47	31	long	long	ADJ
egc-267	47	32	covid19	covid19	NOUN
egc-267	47	33	,	,	PUNCT
egc-267	47	34	indicating	indicate	VERB
egc-267	47	35	that	that	SCONJ
egc-267	47	36	the	the	DET
egc-267	47	37	two	two	NUM
egc-267	47	38	conditions	condition	NOUN
egc-267	47	39	may	may	AUX
egc-267	47	40	share	share	VERB
egc-267	47	41	similar	similar	ADJ
egc-267	47	42	pathophysiological	pathophysiological	ADJ
egc-267	47	43	characteristics	characteristic	NOUN
egc-267	47	44	.	.	PUNCT
egc-267	48	1	[	[	X
egc-267	48	2	2	2	X
egc-267	48	3	]	]	X
egc-267	48	4	[	[	X
egc-267	48	5	6	6	NUM
egc-267	48	6	]	]	X
egc-267	48	7	clinical	clinical	ADJ
egc-267	48	8	manifestations	manifestation	NOUN
egc-267	48	9	and	and	CCONJ
egc-267	48	10	pathophysiological	pathophysiological	ADJ
egc-267	48	11	features	feature	NOUN
egc-267	48	12	immune	immune	ADJ
egc-267	48	13	dysregulation	dysregulation	NOUN
egc-267	48	14	is	be	AUX
egc-267	48	15	a	a	DET
egc-267	48	16	prominent	prominent	ADJ
egc-267	48	17	feature	feature	NOUN
egc-267	48	18	in	in	ADP
egc-267	48	19	both	both	DET
egc-267	48	20	lc	lc	PROPN
egc-267	48	21	and	and	CCONJ
egc-267	48	22	me	i	PRON
egc-267	48	23	/	/	SYM
egc-267	48	24	cfs	cfs	PROPN
egc-267	48	25	.	.	PUNCT
egc-267	49	1	while	while	SCONJ
egc-267	49	2	the	the	DET
egc-267	49	3	onset	onset	NOUN
egc-267	49	4	of	of	ADP
egc-267	49	5	me	i	PRON
egc-267	49	6	/	/	SYM
egc-267	49	7	cfs	cfs	PROPN
egc-267	49	8	often	often	ADV
egc-267	49	9	follows	follow	VERB
egc-267	49	10	an	an	DET
egc-267	49	11	infection	infection	NOUN
egc-267	49	12	,	,	PUNCT
egc-267	49	13	historical	historical	ADJ
egc-267	49	14	research	research	NOUN
egc-267	49	15	has	have	AUX
egc-267	49	16	inadequately	inadequately	ADV
egc-267	49	17	addressed	address	VERB
egc-267	49	18	the	the	DET
egc-267	49	19	multifactorial	multifactorial	ADJ
egc-267	49	20	nature	nature	NOUN
egc-267	49	21	of	of	ADP
egc-267	49	22	infectious	infectious	ADJ
egc-267	49	23	triggers	trigger	NOUN
egc-267	49	24	.	.	PUNCT
egc-267	50	1	recent	recent	ADJ
egc-267	50	2	advancements	advancement	NOUN
egc-267	50	3	in	in	ADP
egc-267	50	4	technologies	technology	NOUN
egc-267	50	5	,	,	PUNCT
egc-267	50	6	such	such	ADJ
egc-267	50	7	as	as	ADP
egc-267	50	8	digital	digital	ADJ
egc-267	50	9	pcr	pcr	PROPN
egc-267	50	10	and	and	CCONJ
egc-267	50	11	multiplex	multiplex	PROPN
egc-267	50	12	masstag	masstag	PROPN
egc-267	50	13	pcr	pcr	PROPN
egc-267	50	14	,	,	PUNCT
egc-267	50	15	have	have	AUX
egc-267	50	16	facilitated	facilitate	VERB
egc-267	50	17	the	the	DET
egc-267	50	18	detection	detection	NOUN
egc-267	50	19	of	of	ADP
egc-267	50	20	low	low	ADJ
egc-267	50	21	-	-	PUNCT
egc-267	50	22	abundance	abundance	NOUN
egc-267	50	23	viral	viral	ADJ
egc-267	50	24	loads	load	NOUN
egc-267	50	25	and	and	CCONJ
egc-267	50	26	multiple	multiple	ADJ
egc-267	50	27	pathogen	pathogen	NOUN
egc-267	50	28	regions	region	NOUN
egc-267	50	29	,	,	PUNCT
egc-267	50	30	revealing	reveal	VERB
egc-267	50	31	a	a	DET
egc-267	50	32	higher	high	ADJ
egc-267	50	33	incidence	incidence	NOUN
egc-267	50	34	of	of	ADP
egc-267	50	35	active	active	ADJ
egc-267	50	36	viral	viral	ADJ
egc-267	50	37	infections	infection	NOUN
egc-267	50	38	in	in	ADP
egc-267	50	39	me	i	PRON
egc-267	50	40	/	/	SYM
egc-267	50	41	cfs	cfs	NOUN
egc-267	50	42	patients	patient	NOUN
egc-267	50	43	.	.	PUNCT
egc-267	51	1	this	this	PRON
egc-267	51	2	correlates	correlate	VERB
egc-267	51	3	with	with	ADP
egc-267	51	4	fatigue	fatigue	NOUN
egc-267	51	5	and	and	CCONJ
egc-267	51	6	neurocognitive	neurocognitive	ADJ
egc-267	51	7	dysfunction	dysfunction	NOUN
egc-267	51	8	and	and	CCONJ
egc-267	51	9	highlights	highlight	NOUN
egc-267	51	10	the	the	DET
egc-267	51	11	role	role	NOUN
egc-267	51	12	of	of	ADP
egc-267	51	13	proinflammatory	proinflammatory	ADJ
egc-267	51	14	cytokines	cytokine	NOUN
egc-267	51	15	,	,	PUNCT
egc-267	51	16	particularly	particularly	ADV
egc-267	51	17	tnf	tnf	PROPN
egc-267	51	18	-	-	PUNCT
egc-267	51	19	α	α	PROPN
egc-267	51	20	.	.	PUNCT
egc-267	52	1	reactivation	reactivation	NOUN
egc-267	52	2	of	of	ADP
egc-267	52	3	latent	latent	NOUN
egc-267	52	4	viruses	virus	NOUN
egc-267	52	5	post-sarshttps://eglobalcongress.com/index.php/egc	post-sarshttps://eglobalcongress.com/index.php/egc	NUM
egc-267	52	6	eglobal	eglobal	PROPN
egc-267	52	7	congress	congress	PROPN
egc-267	52	8	hosted	host	VERB
egc-267	52	9	online	online	ADV
egc-267	52	10	from	from	ADP
egc-267	52	11	dubai	dubai	PROPN
egc-267	52	12	,	,	PUNCT
egc-267	52	13	u.	u.	PROPN
egc-267	52	14	a.	a.	PROPN
egc-267	52	15	e.	e.	PROPN
egc-267	52	16	,	,	PUNCT
egc-267	52	17	e	e	PROPN
egc-267	52	18	conference	conference	NOUN
egc-267	52	19	.	.	PUNCT
egc-267	53	1	date	date	NOUN
egc-267	53	2	:	:	PUNCT
egc-267	53	3	29th	29th	ADJ
egc-267	53	4	october	october	PROPN
egc-267	53	5	2024	2024	NUM
egc-267	53	6	website	website	NOUN
egc-267	53	7	:	:	PUNCT
egc-267	53	8	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-267	53	9	issn	issn	PROPN
egc-267	53	10	(	(	PUNCT
egc-267	53	11	e	e	NOUN
egc-267	53	12	):	):	PUNCT
egc-267	53	13	2836	2836	NUM
egc-267	53	14	-	-	SYM
egc-267	53	15	3612	3612	NUM
egc-267	53	16	78	78	NUM
egc-267	53	17	|	|	ADV
egc-267	53	18	p	p	NOUN
egc-267	53	19	a	a	DET
egc-267	53	20	g	g	NOUN
egc-267	53	21	e	e	NOUN
egc-267	53	22	cov-2	cov-2	PART
egc-267	53	23	infection	infection	NOUN
egc-267	53	24	suggests	suggest	VERB
egc-267	53	25	a	a	DET
egc-267	53	26	contribution	contribution	NOUN
egc-267	53	27	to	to	ADP
egc-267	53	28	the	the	DET
egc-267	53	29	persistence	persistence	NOUN
egc-267	53	30	or	or	CCONJ
egc-267	53	31	exacerbation	exacerbation	NOUN
egc-267	53	32	of	of	ADP
egc-267	53	33	me	i	PRON
egc-267	53	34	/	/	SYM
egc-267	53	35	cfs	cfs	NOUN
egc-267	53	36	symptoms	symptom	NOUN
egc-267	53	37	.	.	PUNCT
egc-267	54	1	•	•	X
egc-267	54	2	rituximab	rituximab	NOUN
egc-267	54	3	:	:	PUNCT
egc-267	54	4	this	this	DET
egc-267	54	5	anti	anti	ADJ
egc-267	54	6	-	-	ADJ
egc-267	54	7	cd20	cd20	ADJ
egc-267	54	8	monoclonal	monoclonal	NOUN
egc-267	54	9	antibody	antibody	NOUN
egc-267	54	10	has	have	AUX
egc-267	54	11	shown	show	VERB
egc-267	54	12	promise	promise	NOUN
egc-267	54	13	in	in	ADP
egc-267	54	14	early	early	ADJ
egc-267	54	15	trials	trial	NOUN
egc-267	54	16	but	but	CCONJ
egc-267	54	17	did	do	AUX
egc-267	54	18	not	not	PART
egc-267	54	19	yield	yield	VERB
egc-267	54	20	significant	significant	ADJ
egc-267	54	21	differences	difference	NOUN
egc-267	54	22	in	in	ADP
egc-267	54	23	response	response	NOUN
egc-267	54	24	rates	rate	NOUN
egc-267	54	25	in	in	ADP
egc-267	54	26	a	a	DET
egc-267	54	27	phase	phase	NOUN
egc-267	54	28	3	3	NUM
egc-267	54	29	trial	trial	NOUN
egc-267	54	30	.	.	PUNCT
egc-267	55	1	•	•	NUM
egc-267	55	2	immunoadsorption	immunoadsorption	NOUN
egc-267	55	3	:	:	PUNCT
egc-267	55	4	currently	currently	ADV
egc-267	55	5	undergoing	undergo	VERB
egc-267	55	6	a	a	DET
egc-267	55	7	randomized	randomized	ADJ
egc-267	55	8	trial	trial	NOUN
egc-267	55	9	(	(	PUNCT
egc-267	55	10	nct05710770	nct05710770	NOUN
egc-267	55	11	)	)	PUNCT
egc-267	55	12	,	,	PUNCT
egc-267	55	13	examining	examine	VERB
egc-267	55	14	its	its	PRON
egc-267	55	15	effects	effect	NOUN
egc-267	55	16	on	on	ADP
egc-267	55	17	me	i	PRON
egc-267	55	18	/	/	SYM
egc-267	55	19	cfs	cfs	PROPN
egc-267	55	20	patients	patient	NOUN
egc-267	55	21	over	over	ADP
egc-267	55	22	multiple	multiple	ADJ
egc-267	55	23	sessions	session	NOUN
egc-267	55	24	.	.	PUNCT
egc-267	56	1	•	•	NUM
egc-267	56	2	rintatolimod	rintatolimod	NOUN
egc-267	56	3	:	:	PUNCT
egc-267	56	4	a	a	DET
egc-267	56	5	phase	phase	NOUN
egc-267	56	6	3	3	NUM
egc-267	56	7	trial	trial	NOUN
egc-267	56	8	(	(	PUNCT
egc-267	56	9	nct00215800	nct00215800	NOUN
egc-267	56	10	)	)	PUNCT
egc-267	56	11	demonstrated	demonstrate	VERB
egc-267	56	12	notable	notable	ADJ
egc-267	56	13	improvements	improvement	NOUN
egc-267	56	14	in	in	ADP
egc-267	56	15	exercise	exercise	NOUN
egc-267	56	16	tolerance	tolerance	NOUN
egc-267	56	17	and	and	CCONJ
egc-267	56	18	quality	quality	NOUN
egc-267	56	19	of	of	ADP
egc-267	56	20	life	life	NOUN
egc-267	56	21	in	in	ADP
egc-267	56	22	a	a	DET
egc-267	56	23	subset	subset	NOUN
egc-267	56	24	of	of	ADP
egc-267	56	25	patients	patient	NOUN
egc-267	56	26	.	.	PUNCT
egc-267	57	1	•	•	NUM
egc-267	57	2	n	n	CCONJ
egc-267	57	3	-	-	PUNCT
egc-267	57	4	acetylcysteine	acetylcysteine	NOUN
egc-267	57	5	:	:	PUNCT
egc-267	57	6	a	a	DET
egc-267	57	7	phase	phase	NOUN
egc-267	57	8	2	2	NUM
egc-267	57	9	trial	trial	NOUN
egc-267	57	10	(	(	PUNCT
egc-267	57	11	nct04542161	nct04542161	NOUN
egc-267	57	12	)	)	PUNCT
egc-267	57	13	is	be	AUX
egc-267	57	14	investigating	investigate	VERB
egc-267	57	15	varying	vary	VERB
egc-267	57	16	dosages	dosage	NOUN
egc-267	57	17	of	of	ADP
egc-267	57	18	this	this	DET
egc-267	57	19	compound	compound	NOUN
egc-267	57	20	to	to	PART
egc-267	57	21	assess	assess	VERB
egc-267	57	22	its	its	PRON
egc-267	57	23	effects	effect	NOUN
egc-267	57	24	on	on	ADP
egc-267	57	25	me	i	PRON
egc-267	57	26	/	/	SYM
egc-267	57	27	cfs	cfs	NOUN
egc-267	57	28	symptoms	symptom	NOUN
egc-267	57	29	.	.	PUNCT
egc-267	58	1	•	•	NUM
egc-267	58	2	despite	despite	SCONJ
egc-267	58	3	inconclusive	inconclusive	ADJ
egc-267	58	4	results	result	NOUN
egc-267	58	5	regarding	regard	VERB
egc-267	58	6	innate	innate	ADJ
egc-267	58	7	immune	immune	ADJ
egc-267	58	8	cell	cell	NOUN
egc-267	58	9	involvement	involvement	NOUN
egc-267	58	10	,	,	PUNCT
egc-267	58	11	emerging	emerge	VERB
egc-267	58	12	evidence	evidence	NOUN
egc-267	58	13	indicates	indicate	VERB
egc-267	58	14	potential	potential	ADJ
egc-267	58	15	quality	quality	NOUN
egc-267	58	16	-	-	PUNCT
egc-267	58	17	of	of	ADP
egc-267	58	18	-	-	PUNCT
egc-267	58	19	life	life	NOUN
egc-267	58	20	improvements	improvement	NOUN
egc-267	58	21	from	from	ADP
egc-267	58	22	targeting	target	VERB
egc-267	58	23	these	these	DET
egc-267	58	24	cells	cell	NOUN
egc-267	58	25	.	.	PUNCT
egc-267	59	1	further	further	ADJ
egc-267	59	2	longitudinal	longitudinal	ADJ
egc-267	59	3	studies	study	NOUN
egc-267	59	4	are	be	AUX
egc-267	59	5	essential	essential	ADJ
egc-267	59	6	for	for	ADP
egc-267	59	7	understanding	understand	VERB
egc-267	59	8	the	the	DET
egc-267	59	9	molecular	molecular	ADJ
egc-267	59	10	changes	change	NOUN
egc-267	59	11	associated	associate	VERB
egc-267	59	12	with	with	ADP
egc-267	59	13	me	i	PRON
egc-267	59	14	/	/	SYM
egc-267	59	15	cfs	cfs	PROPN
egc-267	59	16	.	.	PUNCT
egc-267	60	1	•	•	NUM
egc-267	60	2	both	both	PRON
egc-267	60	3	lc	lc	PROPN
egc-267	60	4	and	and	CCONJ
egc-267	60	5	me	i	PRON
egc-267	60	6	/	/	SYM
egc-267	60	7	cfs	cfs	PROPN
egc-267	60	8	share	share	NOUN
egc-267	60	9	central	central	ADJ
egc-267	60	10	symptoms	symptom	NOUN
egc-267	60	11	of	of	ADP
egc-267	60	12	fatigue	fatigue	NOUN
egc-267	60	13	linked	link	VERB
egc-267	60	14	to	to	ADP
egc-267	60	15	metabolic	metabolic	NOUN
egc-267	60	16	dysfunction	dysfunction	NOUN
egc-267	60	17	.	.	PUNCT
egc-267	61	1	studies	study	NOUN
egc-267	61	2	reveal	reveal	VERB
egc-267	61	3	significant	significant	ADJ
egc-267	61	4	reductions	reduction	NOUN
egc-267	61	5	in	in	ADP
egc-267	61	6	glycolysis	glycolysis	NOUN
egc-267	61	7	and	and	CCONJ
egc-267	61	8	mitochondrial	mitochondrial	ADJ
egc-267	61	9	respiration	respiration	NOUN
egc-267	61	10	in	in	ADP
egc-267	61	11	peripheral	peripheral	ADJ
egc-267	61	12	blood	blood	NOUN
egc-267	61	13	mononuclear	mononuclear	ADJ
egc-267	61	14	cells	cell	NOUN
egc-267	61	15	(	(	PUNCT
egc-267	61	16	pbmcs	pbmcs	NOUN
egc-267	61	17	)	)	PUNCT
egc-267	61	18	from	from	ADP
egc-267	61	19	me	i	PRON
egc-267	61	20	/	/	SYM
egc-267	61	21	cfs	cfs	NOUN
egc-267	61	22	patients	patient	NOUN
egc-267	61	23	.	.	PUNCT
egc-267	62	1	enhanced	enhance	VERB
egc-267	62	2	mtorc1	mtorc1	NOUN
egc-267	62	3	activity	activity	NOUN
egc-267	62	4	suggests	suggest	VERB
egc-267	62	5	dysregulated	dysregulated	ADJ
egc-267	62	6	protein	protein	NOUN
egc-267	62	7	synthesis	synthesis	NOUN
egc-267	62	8	in	in	ADP
egc-267	62	9	mitochondrial	mitochondrial	ADJ
egc-267	62	10	functions	function	NOUN
egc-267	62	11	.	.	PUNCT
egc-267	63	1	•	•	NUM
egc-267	63	2	the	the	DET
egc-267	63	3	gut	gut	NOUN
egc-267	63	4	microbiota	microbiota	NOUN
egc-267	63	5	's	's	PART
egc-267	63	6	interactions	interaction	NOUN
egc-267	63	7	with	with	ADP
egc-267	63	8	immune	immune	ADJ
egc-267	63	9	responses	response	NOUN
egc-267	63	10	and	and	CCONJ
egc-267	63	11	metabolic	metabolic	NOUN
egc-267	63	12	processes	process	NOUN
egc-267	63	13	have	have	AUX
egc-267	63	14	drawn	draw	VERB
egc-267	63	15	increasing	increase	VERB
egc-267	63	16	scrutiny	scrutiny	NOUN
egc-267	63	17	in	in	ADP
egc-267	63	18	me	i	PRON
egc-267	63	19	/	/	SYM
egc-267	63	20	cfs	cfs	PROPN
egc-267	63	21	.	.	PUNCT
egc-267	64	1	while	while	SCONJ
egc-267	64	2	prior	prior	ADJ
egc-267	64	3	studies	study	NOUN
egc-267	64	4	indicated	indicate	VERB
egc-267	64	5	contradictions	contradiction	NOUN
egc-267	64	6	in	in	ADP
egc-267	64	7	microbial	microbial	ADJ
egc-267	64	8	diversity	diversity	NOUN
egc-267	64	9	,	,	PUNCT
egc-267	64	10	recent	recent	ADJ
egc-267	64	11	investigations	investigation	NOUN
egc-267	64	12	highlight	highlight	VERB
egc-267	64	13	the	the	DET
egc-267	64	14	presence	presence	NOUN
egc-267	64	15	of	of	ADP
egc-267	64	16	markers	marker	NOUN
egc-267	64	17	of	of	ADP
egc-267	64	18	intestinal	intestinal	ADJ
egc-267	64	19	damage	damage	NOUN
egc-267	64	20	and	and	CCONJ
egc-267	64	21	altered	alter	VERB
egc-267	64	22	immune	immune	ADJ
egc-267	64	23	responses	response	NOUN
egc-267	64	24	in	in	ADP
egc-267	64	25	cohorts	cohort	NOUN
egc-267	64	26	of	of	ADP
egc-267	64	27	me	i	PRON
egc-267	64	28	/	/	SYM
egc-267	64	29	cfs	cfs	NOUN
egc-267	64	30	patients	patient	NOUN
egc-267	64	31	,	,	PUNCT
egc-267	64	32	underscoring	underscore	VERB
egc-267	64	33	the	the	DET
egc-267	64	34	necessity	necessity	NOUN
egc-267	64	35	of	of	ADP
egc-267	64	36	geographical	geographical	ADJ
egc-267	64	37	and	and	CCONJ
egc-267	64	38	demographic	demographic	ADJ
egc-267	64	39	considerations	consideration	NOUN
egc-267	64	40	in	in	ADP
egc-267	64	41	microbiota	microbiota	NOUN
egc-267	64	42	research	research	NOUN
egc-267	64	43	.	.	PUNCT
egc-267	65	1	•	•	NUM
egc-267	65	2	central	central	ADJ
egc-267	65	3	nervous	nervous	ADJ
egc-267	65	4	system	system	NOUN
egc-267	65	5	(	(	PUNCT
egc-267	65	6	cns	cns	NOUN
egc-267	65	7	)	)	PUNCT
egc-267	65	8	dysfunction	dysfunction	NOUN
egc-267	65	9	is	be	AUX
egc-267	65	10	implicated	implicate	VERB
egc-267	65	11	in	in	ADP
egc-267	65	12	both	both	PRON
egc-267	65	13	me	i	PRON
egc-267	65	14	/	/	SYM
egc-267	65	15	cfs	cfs	PROPN
egc-267	65	16	and	and	CCONJ
egc-267	65	17	lc	lc	PROPN
egc-267	65	18	,	,	PUNCT
egc-267	65	19	characterized	characterize	VERB
egc-267	65	20	by	by	ADP
egc-267	65	21	cognitive	cognitive	ADJ
egc-267	65	22	disturbances	disturbance	NOUN
egc-267	65	23	,	,	PUNCT
egc-267	65	24	fatigue	fatigue	NOUN
egc-267	65	25	,	,	PUNCT
egc-267	65	26	and	and	CCONJ
egc-267	65	27	autonomic	autonomic	ADJ
egc-267	65	28	disruption	disruption	NOUN
egc-267	65	29	.	.	PUNCT
egc-267	66	1	evidence	evidence	NOUN
egc-267	66	2	indicates	indicate	VERB
egc-267	66	3	that	that	SCONJ
egc-267	66	4	viral	viral	ADJ
egc-267	66	5	infections	infection	NOUN
egc-267	66	6	and	and	CCONJ
egc-267	66	7	immune	immune	ADJ
egc-267	66	8	abnormalities	abnormality	NOUN
egc-267	66	9	lead	lead	VERB
egc-267	66	10	to	to	ADP
egc-267	66	11	chronic	chronic	ADJ
egc-267	66	12	neuroinflammation	neuroinflammation	NOUN
egc-267	66	13	,	,	PUNCT
egc-267	66	14	evidenced	evidence	VERB
egc-267	66	15	by	by	ADP
egc-267	66	16	increased	increase	VERB
egc-267	66	17	translocator	translocator	NOUN
egc-267	66	18	protein	protein	NOUN
egc-267	66	19	binding	bind	VERB
egc-267	66	20	in	in	ADP
egc-267	66	21	brain	brain	NOUN
egc-267	66	22	regions	region	NOUN
egc-267	66	23	and	and	CCONJ
egc-267	66	24	neuroimaging	neuroimaging	NOUN
egc-267	66	25	studies	study	NOUN
egc-267	66	26	revealing	reveal	VERB
egc-267	66	27	structural	structural	ADJ
egc-267	66	28	and	and	CCONJ
egc-267	66	29	functional	functional	ADJ
egc-267	66	30	abnormalities	abnormality	NOUN
egc-267	66	31	.	.	PUNCT
egc-267	67	1	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-267	67	2	eglobal	eglobal	PROPN
egc-267	67	3	congress	congress	PROPN
egc-267	67	4	hosted	host	VERB
egc-267	67	5	online	online	ADV
egc-267	67	6	from	from	ADP
egc-267	67	7	dubai	dubai	PROPN
egc-267	67	8	,	,	PUNCT
egc-267	67	9	u.	u.	PROPN
egc-267	67	10	a.	a.	PROPN
egc-267	67	11	e.	e.	PROPN
egc-267	67	12	,	,	PUNCT
egc-267	67	13	e	e	PROPN
egc-267	67	14	conference	conference	NOUN
egc-267	67	15	.	.	PUNCT
egc-267	68	1	date	date	NOUN
egc-267	68	2	:	:	PUNCT
egc-267	68	3	29th	29th	ADJ
egc-267	68	4	october	october	PROPN
egc-267	68	5	2024	2024	NUM
egc-267	68	6	website	website	NOUN
egc-267	68	7	:	:	PUNCT
egc-267	68	8	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-267	68	9	issn	issn	PROPN
egc-267	68	10	(	(	PUNCT
egc-267	68	11	e	e	NOUN
egc-267	68	12	):	):	PUNCT
egc-267	68	13	2836	2836	NUM
egc-267	68	14	-	-	SYM
egc-267	68	15	3612	3612	NUM
egc-267	68	16	79	79	NUM
egc-267	69	1	|	|	ADV
egc-267	69	2	p	p	X
egc-267	69	3	a	a	DET
egc-267	69	4	g	g	NOUN
egc-267	69	5	e	e	NOUN
egc-267	69	6	•	•	NOUN
egc-267	69	7	cardiovascular	cardiovascular	ADJ
egc-267	69	8	dysfunction	dysfunction	NOUN
egc-267	69	9	,	,	PUNCT
egc-267	69	10	including	include	VERB
egc-267	69	11	orthostatic	orthostatic	ADJ
egc-267	69	12	intolerance	intolerance	NOUN
egc-267	69	13	and	and	CCONJ
egc-267	69	14	postural	postural	ADJ
egc-267	69	15	tachycardia	tachycardia	NOUN
egc-267	69	16	syndrome	syndrome	NOUN
egc-267	69	17	(	(	PUNCT
egc-267	69	18	pots	pot	NOUN
egc-267	69	19	)	)	PUNCT
egc-267	69	20	,	,	PUNCT
egc-267	69	21	is	be	AUX
egc-267	69	22	prevalent	prevalent	ADJ
egc-267	69	23	among	among	ADP
egc-267	69	24	me	i	PRON
egc-267	69	25	/	/	SYM
egc-267	69	26	cfs	cfs	NOUN
egc-267	69	27	patients	patient	NOUN
egc-267	69	28	.	.	PUNCT
egc-267	70	1	notably	notably	ADV
egc-267	70	2	,	,	PUNCT
egc-267	70	3	reduced	reduce	VERB
egc-267	70	4	cerebral	cerebral	ADJ
egc-267	70	5	blood	blood	NOUN
egc-267	70	6	flow	flow	NOUN
egc-267	70	7	and	and	CCONJ
egc-267	70	8	other	other	ADJ
egc-267	70	9	vascular	vascular	ADJ
egc-267	70	10	pathologies	pathology	NOUN
egc-267	70	11	pose	pose	VERB
egc-267	70	12	additional	additional	ADJ
egc-267	70	13	risks	risk	NOUN
egc-267	70	14	for	for	ADP
egc-267	70	15	cardiovascular	cardiovascular	ADJ
egc-267	70	16	health	health	NOUN
egc-267	70	17	in	in	ADP
egc-267	70	18	this	this	DET
egc-267	70	19	population	population	NOUN
egc-267	70	20	.	.	PUNCT
egc-267	71	1	[	[	X
egc-267	71	2	5	5	NUM
egc-267	71	3	]	]	PUNCT
egc-267	71	4	•	•	NUM
egc-267	71	5	the	the	DET
egc-267	71	6	heterogeneity	heterogeneity	NOUN
egc-267	71	7	of	of	ADP
egc-267	71	8	symptoms	symptom	NOUN
egc-267	71	9	and	and	CCONJ
egc-267	71	10	long	long	ADJ
egc-267	71	11	-	-	PUNCT
egc-267	71	12	term	term	NOUN
egc-267	71	13	outcomes	outcome	NOUN
egc-267	71	14	complicates	complicate	VERB
egc-267	71	15	the	the	DET
egc-267	71	16	understanding	understanding	NOUN
egc-267	71	17	of	of	ADP
egc-267	71	18	me	i	PRON
egc-267	71	19	/	/	SYM
egc-267	71	20	cfs	cfs	PROPN
egc-267	71	21	and	and	CCONJ
egc-267	71	22	lc	lc	PROPN
egc-267	71	23	.	.	PROPN
egc-267	71	24	enhanced	enhanced	ADJ
egc-267	71	25	awareness	awareness	NOUN
egc-267	71	26	of	of	ADP
egc-267	71	27	lc	lc	PROPN
egc-267	71	28	could	could	AUX
egc-267	71	29	catalyze	catalyze	VERB
egc-267	71	30	research	research	NOUN
egc-267	71	31	and	and	CCONJ
egc-267	71	32	improve	improve	VERB
egc-267	71	33	management	management	NOUN
egc-267	71	34	strategies	strategy	NOUN
egc-267	71	35	for	for	ADP
egc-267	71	36	both	both	DET
egc-267	71	37	conditions	condition	NOUN
egc-267	71	38	.	.	PUNCT
egc-267	72	1	longitudinal	longitudinal	ADJ
egc-267	72	2	studies	study	NOUN
egc-267	72	3	focusing	focus	VERB
egc-267	72	4	on	on	ADP
egc-267	72	5	risk	risk	NOUN
egc-267	72	6	factors	factor	NOUN
egc-267	72	7	and	and	CCONJ
egc-267	72	8	clinical	clinical	ADJ
egc-267	72	9	phenotypes	phenotype	NOUN
egc-267	72	10	are	be	AUX
egc-267	72	11	vital	vital	ADJ
egc-267	72	12	for	for	ADP
egc-267	72	13	tailored	tailor	VERB
egc-267	72	14	interventions	intervention	NOUN
egc-267	72	15	,	,	PUNCT
egc-267	72	16	integrating	integrate	VERB
egc-267	72	17	clinical	clinical	ADJ
egc-267	72	18	data	datum	NOUN
egc-267	72	19	with	with	ADP
egc-267	72	20	biological	biological	ADJ
egc-267	72	21	analyses	analysis	NOUN
egc-267	72	22	.	.	PUNCT
egc-267	73	1	•	•	X
egc-267	73	2	there	there	PRON
egc-267	73	3	are	be	VERB
egc-267	73	4	three	three	NUM
egc-267	73	5	broad	broad	ADJ
egc-267	73	6	categories	category	NOUN
egc-267	73	7	of	of	ADP
egc-267	73	8	pasc	pasc	ADJ
egc-267	73	9	:	:	PUNCT
egc-267	73	10	tissue	tissue	NOUN
egc-267	73	11	injury	injury	NOUN
egc-267	73	12	of	of	ADP
egc-267	73	13	multiple	multiple	ADJ
egc-267	73	14	organs	organ	NOUN
egc-267	73	15	,	,	PUNCT
egc-267	73	16	new	new	ADJ
egc-267	73	17	onset	onset	NOUN
egc-267	73	18	of	of	ADP
egc-267	73	19	major	major	ADJ
egc-267	73	20	diseases	disease	NOUN
egc-267	73	21	(	(	PUNCT
egc-267	73	22	diabetes	diabetes	NOUN
egc-267	73	23	mellitus	mellitus	NOUN
egc-267	73	24	,	,	PUNCT
egc-267	73	25	cardiovascular	cardiovascular	ADJ
egc-267	73	26	diseases	disease	NOUN
egc-267	73	27	,	,	PUNCT
egc-267	73	28	pulmonary	pulmonary	ADJ
egc-267	73	29	failure	failure	NOUN
egc-267	73	30	)	)	PUNCT
egc-267	73	31	and	and	CCONJ
egc-267	73	32	long	long	ADJ
egc-267	73	33	covid	covid	NOUN
egc-267	73	34	.	.	PUNCT
egc-267	74	1	•	•	NUM
egc-267	74	2	the	the	DET
egc-267	74	3	cdc	cdc	PROPN
egc-267	74	4	states	state	VERB
egc-267	74	5	that	that	SCONJ
egc-267	74	6	in	in	ADP
egc-267	74	7	the	the	DET
egc-267	74	8	“	"	PUNCT
egc-267	74	9	post	post	ADJ
egc-267	74	10	-	-	ADJ
egc-267	74	11	covid	covid	ADJ
egc-267	74	12	condition	condition	NOUN
egc-267	74	13	”	"	PUNCT
egc-267	74	14	symptoms	symptom	NOUN
egc-267	74	15	can	can	AUX
egc-267	74	16	continue	continue	VERB
egc-267	74	17	for	for	ADP
egc-267	74	18	four	four	NUM
egc-267	74	19	or	or	CCONJ
egc-267	74	20	more	more	ADJ
egc-267	74	21	weeks	week	NOUN
egc-267	74	22	after	after	ADP
egc-267	74	23	infection	infection	NOUN
egc-267	74	24	with	with	ADP
egc-267	74	25	sars	sar	NOUN
egc-267	74	26	-	-	PUNCT
egc-267	74	27	cov-2	cov-2	NOUN
egc-267	74	28	.	.	PUNCT
egc-267	75	1	according	accord	VERB
egc-267	75	2	to	to	ADP
egc-267	75	3	the	the	DET
egc-267	75	4	world	world	PROPN
egc-267	75	5	health	health	NOUN
egc-267	75	6	organization	organization	NOUN
egc-267	75	7	this	this	DET
egc-267	75	8	condition	condition	NOUN
egc-267	75	9	is	be	AUX
egc-267	75	10	defined	define	VERB
egc-267	75	11	by	by	ADP
egc-267	75	12	continuation	continuation	NOUN
egc-267	75	13	or	or	CCONJ
egc-267	75	14	development	development	NOUN
egc-267	75	15	of	of	ADP
egc-267	75	16	new	new	ADJ
egc-267	75	17	symptoms	symptom	NOUN
egc-267	75	18	3	3	NUM
egc-267	75	19	months	month	NOUN
egc-267	75	20	after	after	ADP
egc-267	75	21	the	the	DET
egc-267	75	22	initial	initial	ADJ
egc-267	75	23	sars	sar	NOUN
egc-267	75	24	-	-	PUNCT
egc-267	75	25	cov-2	cov-2	PART
egc-267	75	26	infection	infection	NOUN
egc-267	75	27	,	,	PUNCT
egc-267	75	28	lasting	last	VERB
egc-267	75	29	for	for	ADP
egc-267	75	30	at	at	ADV
egc-267	75	31	least	least	ADV
egc-267	75	32	2	2	NUM
egc-267	75	33	months	month	NOUN
egc-267	75	34	with	with	ADP
egc-267	75	35	no	no	DET
egc-267	75	36	other	other	ADJ
egc-267	75	37	explanation	explanation	NOUN
egc-267	75	38	.	.	PUNCT
egc-267	76	1	some	some	DET
egc-267	76	2	evidence	evidence	NOUN
egc-267	76	3	indicates	indicate	VERB
egc-267	76	4	that	that	SCONJ
egc-267	76	5	long	long	ADJ
egc-267	76	6	covid	covid	NOUN
egc-267	76	7	is	be	AUX
egc-267	76	8	more	more	ADV
egc-267	76	9	likely	likely	ADJ
egc-267	76	10	to	to	PART
egc-267	76	11	develop	develop	VERB
egc-267	76	12	in	in	ADP
egc-267	76	13	people	people	NOUN
egc-267	76	14	with	with	ADP
egc-267	76	15	prior	prior	ADJ
egc-267	76	16	medical	medical	ADJ
egc-267	76	17	history	history	NOUN
egc-267	76	18	of	of	ADP
egc-267	76	19	sickness	sickness	NOUN
egc-267	76	20	,	,	PUNCT
egc-267	76	21	previous	previous	ADJ
egc-267	76	22	inflammation	inflammation	NOUN
egc-267	76	23	with	with	ADP
egc-267	76	24	acute	acute	NOUN
egc-267	76	25	covid-19	covid-19	PROPN
egc-267	76	26	;	;	PUNCT
egc-267	76	27	were	be	AUX
egc-267	76	28	pcr	pcr	ADV
egc-267	76	29	positive	positive	ADJ
egc-267	76	30	;	;	PUNCT
egc-267	76	31	female	female	ADJ
egc-267	76	32	;	;	PUNCT
egc-267	76	33	and	and	CCONJ
egc-267	76	34	have	have	VERB
egc-267	76	35	a	a	DET
egc-267	76	36	premorbid	premorbid	ADJ
egc-267	76	37	history	history	NOUN
egc-267	76	38	of	of	ADP
egc-267	76	39	asthma	asthma	NOUN
egc-267	76	40	,	,	PUNCT
egc-267	76	41	chronic	chronic	ADJ
egc-267	76	42	obstructive	obstructive	ADJ
egc-267	76	43	pulmonary	pulmonary	ADJ
egc-267	76	44	disease	disease	NOUN
egc-267	76	45	and	and	CCONJ
egc-267	76	46	depression	depression	NOUN
egc-267	76	47	.	.	PUNCT
egc-267	77	1	but	but	CCONJ
egc-267	77	2	many	many	ADJ
egc-267	77	3	patients	patient	NOUN
egc-267	77	4	had	have	VERB
egc-267	77	5	none	none	NOUN
egc-267	77	6	of	of	ADP
egc-267	77	7	these	these	DET
egc-267	77	8	symptoms	symptom	NOUN
egc-267	77	9	.	.	PUNCT
egc-267	78	1	the	the	DET
egc-267	78	2	severity	severity	NOUN
egc-267	78	3	of	of	ADP
egc-267	78	4	the	the	DET
egc-267	78	5	symptoms	symptom	NOUN
egc-267	78	6	,	,	PUNCT
egc-267	78	7	and	and	CCONJ
egc-267	78	8	the	the	DET
egc-267	78	9	functional	functional	ADJ
egc-267	78	10	impairment	impairment	NOUN
egc-267	78	11	,	,	PUNCT
egc-267	78	12	can	can	AUX
egc-267	78	13	be	be	AUX
egc-267	78	14	various	various	ADJ
egc-267	78	15	.	.	PUNCT
egc-267	79	1	the	the	DET
egc-267	79	2	functional	functional	ADJ
egc-267	79	3	impairment	impairment	NOUN
egc-267	79	4	in	in	ADP
egc-267	79	5	people	people	NOUN
egc-267	79	6	with	with	ADP
egc-267	79	7	me	i	PRON
egc-267	79	8	/	/	SYM
egc-267	79	9	cfs	cfs	PROPN
egc-267	79	10	may	may	AUX
egc-267	79	11	be	be	AUX
egc-267	79	12	even	even	ADV
egc-267	79	13	greater	great	ADJ
egc-267	79	14	than	than	ADP
egc-267	79	15	in	in	ADP
egc-267	79	16	those	those	PRON
egc-267	79	17	with	with	ADP
egc-267	79	18	long	long	ADJ
egc-267	79	19	covid	covid	NOUN
egc-267	79	20	.	.	PUNCT
egc-267	80	1	some	some	DET
egc-267	80	2	people	people	NOUN
egc-267	80	3	are	be	AUX
egc-267	80	4	able	able	ADJ
egc-267	80	5	to	to	PART
egc-267	80	6	live	live	VERB
egc-267	80	7	normally	normally	ADV
egc-267	80	8	,	,	PUNCT
egc-267	80	9	some	some	PRON
egc-267	80	10	may	may	AUX
egc-267	80	11	stay	stay	VERB
egc-267	80	12	bed	bed	NOUN
egc-267	80	13	-	-	PUNCT
egc-267	80	14	ridden	ride	VERB
egc-267	80	15	.	.	PUNCT
egc-267	81	1	the	the	DET
egc-267	81	2	symptoms	symptom	NOUN
egc-267	81	3	are	be	AUX
egc-267	81	4	often	often	ADV
egc-267	81	5	cyclic	cyclic	ADJ
egc-267	81	6	,	,	PUNCT
egc-267	81	7	worsening	worsen	VERB
egc-267	81	8	by	by	ADP
egc-267	81	9	stressors	stressor	NOUN
egc-267	81	10	—	—	PUNCT
egc-267	81	11	exercise	exercise	NOUN
egc-267	81	12	,	,	PUNCT
egc-267	81	13	prolonged	prolong	VERB
egc-267	81	14	upright	upright	ADJ
egc-267	81	15	position	position	NOUN
egc-267	81	16	,	,	PUNCT
egc-267	81	17	cognitive	cognitive	ADJ
egc-267	81	18	and	and	CCONJ
egc-267	81	19	emotional	emotional	ADJ
egc-267	81	20	upset	upset	ADJ
egc-267	81	21	.	.	PUNCT
egc-267	82	1	it	it	PRON
egc-267	82	2	should	should	AUX
egc-267	82	3	be	be	AUX
egc-267	82	4	noted	note	VERB
egc-267	82	5	that	that	SCONJ
egc-267	82	6	attempts	attempt	VERB
egc-267	82	7	to	to	PART
egc-267	82	8	identify	identify	VERB
egc-267	82	9	a	a	DET
egc-267	82	10	single	single	ADJ
egc-267	82	11	and	and	CCONJ
egc-267	82	12	possibly	possibly	ADV
egc-267	82	13	novel	novel	VERB
egc-267	82	14	infectious	infectious	ADJ
egc-267	82	15	agent	agent	NOUN
egc-267	82	16	as	as	ADP
egc-267	82	17	the	the	DET
egc-267	82	18	cause	cause	NOUN
egc-267	82	19	of	of	ADP
egc-267	82	20	most	most	ADJ
egc-267	82	21	cases	case	NOUN
egc-267	82	22	of	of	ADP
egc-267	82	23	me	i	PRON
egc-267	82	24	/	/	SYM
egc-267	82	25	cfs	cfs	PROPN
egc-267	82	26	have	have	AUX
egc-267	82	27	been	be	AUX
egc-267	82	28	unsuccessful	unsuccessful	ADJ
egc-267	82	29	.	.	PUNCT
egc-267	83	1	magnetic	magnetic	ADJ
egc-267	83	2	resonance	resonance	NOUN
egc-267	83	3	imaging	imaging	NOUN
egc-267	83	4	(	(	PUNCT
egc-267	83	5	mri	mri	NOUN
egc-267	83	6	)	)	PUNCT
egc-267	83	7	has	have	AUX
egc-267	83	8	shown	show	VERB
egc-267	83	9	abnormalities	abnormality	NOUN
egc-267	83	10	involving	involve	VERB
egc-267	83	11	both	both	CCONJ
egc-267	83	12	gray	gray	ADJ
egc-267	83	13	matter	matter	NOUN
egc-267	83	14	and	and	CCONJ
egc-267	83	15	white	white	ADJ
egc-267	83	16	matter	matter	NOUN
egc-267	83	17	have	have	AUX
egc-267	83	18	been	be	AUX
egc-267	83	19	found	find	VERB
egc-267	83	20	in	in	ADP
egc-267	83	21	both	both	DET
egc-267	83	22	illnesses	illness	NOUN
egc-267	83	23	.	.	PUNCT
egc-267	84	1	myalgic	myalgic	ADJ
egc-267	84	2	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	ADJ
egc-267	84	3	eglobal	eglobal	PROPN
egc-267	84	4	congress	congress	PROPN
egc-267	84	5	hosted	host	VERB
egc-267	84	6	online	online	ADV
egc-267	84	7	from	from	ADP
egc-267	84	8	dubai	dubai	PROPN
egc-267	84	9	,	,	PUNCT
egc-267	84	10	u.	u.	PROPN
egc-267	84	11	a.	a.	PROPN
egc-267	84	12	e.	e.	PROPN
egc-267	84	13	,	,	PUNCT
egc-267	84	14	e	e	PROPN
egc-267	84	15	conference	conference	NOUN
egc-267	84	16	.	.	PUNCT
egc-267	85	1	date	date	NOUN
egc-267	85	2	:	:	PUNCT
egc-267	85	3	29th	29th	ADJ
egc-267	85	4	october	october	PROPN
egc-267	85	5	2024	2024	NUM
egc-267	85	6	website	website	NOUN
egc-267	85	7	:	:	PUNCT
egc-267	85	8	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-267	85	9	issn	issn	PROPN
egc-267	85	10	(	(	PUNCT
egc-267	85	11	e	e	NOUN
egc-267	85	12	):	):	PUNCT
egc-267	85	13	2836	2836	NUM
egc-267	85	14	-	-	SYM
egc-267	85	15	3612	3612	NUM
egc-267	85	16	80	80	NUM
egc-267	85	17	|	|	ADV
egc-267	85	18	p	p	NOUN
egc-267	85	19	a	a	DET
egc-267	85	20	g	g	NOUN
egc-267	85	21	e	e	NOUN
egc-267	85	22	encephalomyelitis	encephalomyelitis	X
egc-267	85	23	/	/	SYM
egc-267	85	24	cfs	cfs	PROPN
egc-267	85	25	often	often	ADV
egc-267	85	26	follows	follow	VERB
egc-267	85	27	in	in	ADP
egc-267	85	28	the	the	DET
egc-267	85	29	wake	wake	NOUN
egc-267	85	30	of	of	ADP
egc-267	85	31	an	an	DET
egc-267	85	32	“	"	PUNCT
egc-267	85	33	infectious	infectious	ADJ
egc-267	85	34	-	-	PUNCT
egc-267	85	35	like	like	ADJ
egc-267	85	36	”	"	PUNCT
egc-267	85	37	illness	illness	NOUN
egc-267	85	38	while	while	SCONJ
egc-267	85	39	long	long	ADJ
egc-267	85	40	covid	covid	PROPN
egc-267	85	41	follows	follow	VERB
egc-267	85	42	acute	acute	ADJ
egc-267	85	43	infection	infection	NOUN
egc-267	85	44	with	with	ADP
egc-267	85	45	sars	sar	NOUN
egc-267	85	46	-	-	PUNCT
egc-267	85	47	cov-2	cov-2	NOUN
egc-267	85	48	.	.	PUNCT
egc-267	86	1	a	a	DET
egc-267	86	2	variety	variety	NOUN
egc-267	86	3	of	of	ADP
egc-267	86	4	immunological	immunological	ADJ
egc-267	86	5	parameters	parameter	NOUN
egc-267	86	6	distinguish	distinguish	VERB
egc-267	86	7	people	people	NOUN
egc-267	86	8	with	with	ADP
egc-267	86	9	me	i	PRON
egc-267	86	10	/	/	SYM
egc-267	86	11	cfs	cfs	PROPN
egc-267	86	12	from	from	ADP
egc-267	86	13	healthy	healthy	ADJ
egc-267	86	14	patients	patient	NOUN
egc-267	86	15	the	the	DET
egc-267	86	16	same	same	ADJ
egc-267	86	17	is	be	AUX
egc-267	86	18	true	true	ADJ
egc-267	86	19	of	of	ADP
egc-267	86	20	long	long	ADJ
egc-267	86	21	covid	covid	NOUN
egc-267	86	22	,	,	PUNCT
egc-267	86	23	abnormalities	abnormality	NOUN
egc-267	86	24	in	in	ADP
egc-267	86	25	redox	redox	ADJ
egc-267	86	26	balance	balance	NOUN
egc-267	86	27	,	,	PUNCT
egc-267	86	28	and	and	CCONJ
egc-267	86	29	in	in	ADP
egc-267	86	30	the	the	DET
egc-267	86	31	kynurenine	kynurenine	NOUN
egc-267	86	32	pathway	pathway	NOUN
egc-267	86	33	has	have	AUX
egc-267	86	34	been	be	AUX
egc-267	86	35	seen	see	VERB
egc-267	86	36	in	in	ADP
egc-267	86	37	both	both	DET
egc-267	86	38	illnesses	illness	NOUN
egc-267	86	39	.	.	PUNCT
egc-267	87	1	it	it	PRON
egc-267	87	2	has	have	AUX
egc-267	87	3	been	be	AUX
egc-267	87	4	studied	study	VERB
egc-267	87	5	less	less	ADV
egc-267	87	6	extensively	extensively	ADV
egc-267	87	7	but	but	CCONJ
egc-267	87	8	growing	grow	VERB
egc-267	87	9	number	number	NOUN
egc-267	87	10	of	of	ADP
egc-267	87	11	cardiopulmonary	cardiopulmonary	ADJ
egc-267	87	12	abnormalities	abnormality	NOUN
egc-267	87	13	have	have	AUX
egc-267	87	14	been	be	AUX
egc-267	87	15	noted	note	VERB
egc-267	87	16	.	.	PUNCT
egc-267	88	1	not	not	PART
egc-267	88	2	only	only	ADV
egc-267	88	3	is	be	AUX
egc-267	88	4	a	a	DET
egc-267	88	5	common	common	ADJ
egc-267	88	6	core	core	NOUN
egc-267	88	7	of	of	ADP
egc-267	88	8	symptoms	symptom	NOUN
egc-267	88	9	shared	share	VERB
egc-267	88	10	by	by	ADP
egc-267	88	11	me	i	PRON
egc-267	88	12	/	/	SYM
egc-267	88	13	cfs	cfs	PROPN
egc-267	88	14	and	and	CCONJ
egc-267	88	15	long	long	ADJ
egc-267	88	16	covid	covid	NOUN
egc-267	88	17	:	:	PUNCT
egc-267	88	18	these	these	DET
egc-267	88	19	same	same	ADJ
egc-267	88	20	symptoms	symptom	NOUN
egc-267	88	21	also	also	ADV
egc-267	88	22	are	be	AUX
egc-267	88	23	also	also	ADV
egc-267	88	24	reported	report	VERB
egc-267	88	25	following	follow	VERB
egc-267	88	26	multiple	multiple	ADJ
egc-267	88	27	infectious	infectious	ADJ
egc-267	88	28	illnesses	illness	NOUN
egc-267	88	29	and	and	CCONJ
egc-267	88	30	major	major	ADJ
egc-267	88	31	non	non	ADJ
egc-267	88	32	-	-	ADJ
egc-267	88	33	infectious	infectious	ADJ
egc-267	88	34	injury	injury	NOUN
egc-267	88	35	such	such	ADJ
egc-267	88	36	as	as	ADP
egc-267	88	37	post	post	ADJ
egc-267	88	38	-	-	ADJ
egc-267	88	39	critical	critical	ADJ
egc-267	88	40	illness	illness	NOUN
egc-267	88	41	syndrome	syndrome	NOUN
egc-267	88	42	or	or	CCONJ
egc-267	88	43	post	post	ADJ
egc-267	88	44	-	-	ADJ
egc-267	88	45	intensive	intensive	ADJ
egc-267	88	46	care	care	NOUN
egc-267	88	47	unit	unit	NOUN
egc-267	88	48	syndrome	syndrome	NOUN
egc-267	88	49	,	,	PUNCT
egc-267	88	50	including	include	VERB
egc-267	88	51	heat	heat	NOUN
egc-267	88	52	stroke	stroke	NOUN
egc-267	88	53	.	.	PUNCT
egc-267	89	1	both	both	PRON
egc-267	89	2	of	of	ADP
egc-267	89	3	this	this	DET
egc-267	89	4	diseases	disease	NOUN
egc-267	89	5	clearly	clearly	ADV
egc-267	89	6	are	be	AUX
egc-267	89	7	systemic	systemic	ADJ
egc-267	89	8	illnesses	illness	NOUN
egc-267	89	9	,	,	PUNCT
egc-267	89	10	involve	involve	VERB
egc-267	89	11	multiple	multiple	ADJ
egc-267	89	12	organs	organ	NOUN
egc-267	89	13	and	and	CCONJ
egc-267	89	14	physiological	physiological	ADJ
egc-267	89	15	systems	system	NOUN
egc-267	89	16	.	.	PUNCT
egc-267	90	1	me	i	PRON
egc-267	90	2	/	/	SYM
egc-267	90	3	cfs	cf	NOUN
egc-267	90	4	more	more	ADV
egc-267	90	5	likely	likely	ADV
egc-267	90	6	represents	represent	VERB
egc-267	90	7	a	a	DET
egc-267	90	8	dysfunctional	dysfunctional	ADJ
egc-267	90	9	response	response	NOUN
egc-267	90	10	to	to	ADP
egc-267	90	11	infection	infection	NOUN
egc-267	90	12	.	.	PUNCT
egc-267	91	1	both	both	DET
egc-267	91	2	illnesses	illness	NOUN
egc-267	91	3	share	share	VERB
egc-267	91	4	abnormalities	abnormality	NOUN
egc-267	91	5	involving	involve	VERB
egc-267	91	6	the	the	DET
egc-267	91	7	central	central	ADJ
egc-267	91	8	and	and	CCONJ
egc-267	91	9	autonomic	autonomic	ADJ
egc-267	91	10	nervous	nervous	ADJ
egc-267	91	11	systems	system	NOUN
egc-267	91	12	,	,	PUNCT
egc-267	91	13	the	the	DET
egc-267	91	14	immune	immune	ADJ
egc-267	91	15	system	system	NOUN
egc-267	91	16	,	,	PUNCT
egc-267	91	17	reactivation	reactivation	NOUN
egc-267	91	18	of	of	ADP
egc-267	91	19	latent	latent	NOUN
egc-267	91	20	infectious	infectious	ADJ
egc-267	91	21	agents	agent	NOUN
egc-267	91	22	(	(	PUNCT
egc-267	91	23	primarily	primarily	ADV
egc-267	91	24	herpesviruses	herpesviruse	NOUN
egc-267	91	25	)	)	PUNCT
egc-267	91	26	,	,	PUNCT
egc-267	91	27	the	the	DET
egc-267	91	28	gut	gut	NOUN
egc-267	91	29	microbiome	microbiome	NOUN
egc-267	91	30	,	,	PUNCT
egc-267	91	31	energy	energy	NOUN
egc-267	91	32	metabolism	metabolism	NOUN
egc-267	91	33	,	,	PUNCT
egc-267	91	34	a	a	DET
egc-267	91	35	hypometabolic	hypometabolic	ADJ
egc-267	91	36	state	state	NOUN
egc-267	91	37	,	,	PUNCT
egc-267	91	38	redox	redox	ADJ
egc-267	91	39	imbalance	imbalance	NOUN
egc-267	91	40	,	,	PUNCT
egc-267	91	41	and	and	CCONJ
egc-267	91	42	various	various	ADJ
egc-267	91	43	cardiac	cardiac	ADJ
egc-267	91	44	,	,	PUNCT
egc-267	91	45	pulmonary	pulmonary	ADJ
egc-267	91	46	and	and	CCONJ
egc-267	91	47	vascular	vascular	ADJ
egc-267	91	48	abnormalities	abnormality	NOUN
egc-267	91	49	.	.	PUNCT
egc-267	92	1	many	many	ADJ
egc-267	92	2	of	of	ADP
egc-267	92	3	which	which	PRON
egc-267	92	4	influence	influence	NOUN
egc-267	92	5	each	each	DET
egc-267	92	6	other	other	ADJ
egc-267	92	7	and	and	CCONJ
egc-267	92	8	crate	crate	VERB
egc-267	92	9	a	a	DET
egc-267	92	10	vicious	vicious	ADJ
egc-267	92	11	cycle	cycle	NOUN
egc-267	92	12	.	.	PUNCT
egc-267	93	1	but	but	CCONJ
egc-267	93	2	the	the	DET
egc-267	93	3	process	process	NOUN
egc-267	93	4	may	may	AUX
egc-267	93	5	be	be	AUX
egc-267	93	6	different	different	ADJ
egc-267	93	7	in	in	ADP
egc-267	93	8	one	one	NUM
egc-267	93	9	person	person	NOUN
egc-267	93	10	with	with	ADP
egc-267	93	11	the	the	DET
egc-267	93	12	illness	illness	NOUN
egc-267	93	13	from	from	ADP
egc-267	93	14	another	another	PRON
egc-267	93	15	.	.	PUNCT
egc-267	94	1	the	the	DET
egc-267	94	2	often	often	ADV
egc-267	94	3	-	-	PUNCT
egc-267	94	4	similar	similar	ADJ
egc-267	94	5	findings	finding	NOUN
egc-267	94	6	suggest	suggest	VERB
egc-267	94	7	that	that	SCONJ
egc-267	94	8	insights	insight	NOUN
egc-267	94	9	into	into	ADP
egc-267	94	10	each	each	DET
egc-267	94	11	disorder	disorder	NOUN
egc-267	94	12	will	will	AUX
egc-267	94	13	have	have	VERB
egc-267	94	14	implications	implication	NOUN
egc-267	94	15	for	for	ADP
egc-267	94	16	the	the	DET
egc-267	94	17	other	other	ADJ
egc-267	94	18	.	.	PUNCT
egc-267	95	1	they	they	PRON
egc-267	95	2	may	may	AUX
egc-267	95	3	also	also	ADV
egc-267	95	4	enhance	enhance	VERB
egc-267	95	5	our	our	PRON
egc-267	95	6	understanding	understanding	NOUN
egc-267	95	7	of	of	ADP
egc-267	95	8	evolutionarily	evolutionarily	ADV
egc-267	95	9	preserved	preserve	VERB
egc-267	95	10	biological	biological	ADJ
egc-267	95	11	responses	response	NOUN
egc-267	95	12	that	that	PRON
egc-267	95	13	fight	fight	VERB
egc-267	95	14	infection	infection	NOUN
egc-267	95	15	.	.	PUNCT
egc-267	96	1	[	[	X
egc-267	96	2	4	4	X
egc-267	96	3	]	]	X
egc-267	96	4	[	[	X
egc-267	96	5	7	7	X
egc-267	96	6	]	]	PUNCT
egc-267	96	7	conclusions	conclusion	NOUN
egc-267	96	8	the	the	DET
egc-267	96	9	global	global	ADJ
egc-267	96	10	prevalence	prevalence	NOUN
egc-267	96	11	of	of	ADP
egc-267	96	12	covid-19	covid-19	PROPN
egc-267	96	13	and	and	CCONJ
egc-267	96	14	chronic	chronic	ADJ
egc-267	96	15	fatigue	fatigue	NOUN
egc-267	96	16	syndrome	syndrome	NOUN
egc-267	96	17	(	(	PUNCT
egc-267	96	18	cfs	cfs	PROPN
egc-267	96	19	)	)	PUNCT
egc-267	96	20	presents	present	VERB
egc-267	96	21	a	a	DET
egc-267	96	22	complex	complex	ADJ
egc-267	96	23	public	public	ADJ
egc-267	96	24	health	health	NOUN
egc-267	96	25	challenge	challenge	NOUN
egc-267	96	26	due	due	ADP
egc-267	96	27	to	to	ADP
egc-267	96	28	their	their	PRON
egc-267	96	29	overlapping	overlap	VERB
egc-267	96	30	symptoms	symptom	NOUN
egc-267	96	31	and	and	CCONJ
egc-267	96	32	shared	shared	ADJ
egc-267	96	33	mechanisms	mechanism	NOUN
egc-267	96	34	,	,	PUNCT
egc-267	96	35	such	such	ADJ
egc-267	96	36	as	as	ADP
egc-267	96	37	immune	immune	ADJ
egc-267	96	38	dysregulation	dysregulation	NOUN
egc-267	96	39	and	and	CCONJ
egc-267	96	40	persistent	persistent	ADJ
egc-267	96	41	fatigue	fatigue	NOUN
egc-267	96	42	.	.	PUNCT
egc-267	97	1	the	the	DET
egc-267	97	2	widespread	widespread	ADJ
egc-267	97	3	impact	impact	NOUN
egc-267	97	4	of	of	ADP
egc-267	97	5	covid-19	covid-19	PROPN
egc-267	97	6	,	,	PUNCT
egc-267	97	7	particularly	particularly	ADV
egc-267	97	8	through	through	ADP
egc-267	97	9	long	long	ADJ
egc-267	97	10	covid	covid	NOUN
egc-267	97	11	,	,	PUNCT
egc-267	97	12	has	have	AUX
egc-267	97	13	led	lead	VERB
egc-267	97	14	to	to	ADP
egc-267	97	15	an	an	DET
egc-267	97	16	increase	increase	NOUN
egc-267	97	17	in	in	ADP
egc-267	97	18	cfs	cfs	NOUN
egc-267	97	19	-	-	PUNCT
egc-267	97	20	like	like	ADJ
egc-267	97	21	conditions	condition	NOUN
egc-267	97	22	,	,	PUNCT
egc-267	97	23	underscoring	underscore	VERB
egc-267	97	24	the	the	DET
egc-267	97	25	importance	importance	NOUN
egc-267	97	26	of	of	ADP
egc-267	97	27	developing	develop	VERB
egc-267	97	28	clear	clear	ADJ
egc-267	97	29	diagnostic	diagnostic	ADJ
egc-267	97	30	criteria	criterion	NOUN
egc-267	97	31	and	and	CCONJ
egc-267	97	32	improved	improve	VERB
egc-267	97	33	understanding	understanding	NOUN
egc-267	97	34	of	of	ADP
egc-267	97	35	these	these	DET
egc-267	97	36	syndromes	syndrome	NOUN
egc-267	97	37	.	.	PUNCT
egc-267	98	1	enhanced	enhance	VERB
egc-267	98	2	research	research	NOUN
egc-267	98	3	efforts	effort	NOUN
egc-267	98	4	and	and	CCONJ
egc-267	98	5	public	public	ADJ
egc-267	98	6	health	health	NOUN
egc-267	98	7	strategies	strategy	NOUN
egc-267	98	8	are	be	AUX
egc-267	98	9	needed	need	VERB
egc-267	98	10	to	to	PART
egc-267	98	11	address	address	VERB
egc-267	98	12	the	the	DET
egc-267	98	13	growing	grow	VERB
egc-267	98	14	burden	burden	NOUN
egc-267	98	15	of	of	ADP
egc-267	98	16	these	these	DET
egc-267	98	17	conditions	condition	NOUN
egc-267	98	18	,	,	PUNCT
egc-267	98	19	supporting	support	VERB
egc-267	98	20	both	both	PRON
egc-267	98	21	prevention	prevention	NOUN
egc-267	98	22	and	and	CCONJ
egc-267	98	23	patient	patient	NOUN
egc-267	98	24	care	care	NOUN
egc-267	98	25	while	while	SCONJ
egc-267	98	26	aiming	aim	VERB
egc-267	98	27	to	to	PART
egc-267	98	28	mitigate	mitigate	VERB
egc-267	98	29	their	their	PRON
egc-267	98	30	economic	economic	ADJ
egc-267	98	31	and	and	CCONJ
egc-267	98	32	social	social	ADJ
egc-267	98	33	impacts	impact	NOUN
egc-267	98	34	globally	globally	ADV
egc-267	98	35	.	.	PUNCT
egc-267	99	1	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-267	99	2	eglobal	eglobal	PROPN
egc-267	99	3	congress	congress	PROPN
egc-267	99	4	hosted	host	VERB
egc-267	99	5	online	online	ADV
egc-267	99	6	from	from	ADP
egc-267	99	7	dubai	dubai	PROPN
egc-267	99	8	,	,	PUNCT
egc-267	99	9	u.	u.	PROPN
egc-267	99	10	a.	a.	PROPN
egc-267	99	11	e.	e.	PROPN
egc-267	99	12	,	,	PUNCT
egc-267	99	13	e	e	PROPN
egc-267	99	14	conference	conference	NOUN
egc-267	99	15	.	.	PUNCT
egc-267	100	1	date	date	NOUN
egc-267	100	2	:	:	PUNCT
egc-267	100	3	29th	29th	ADJ
egc-267	100	4	october	october	PROPN
egc-267	100	5	2024	2024	NUM
egc-267	100	6	website	website	NOUN
egc-267	100	7	:	:	PUNCT
egc-267	100	8	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-267	100	9	issn	issn	PROPN
egc-267	100	10	(	(	PUNCT
egc-267	100	11	e	e	NOUN
egc-267	100	12	):	):	PUNCT
egc-267	100	13	2836	2836	NUM
egc-267	100	14	-	-	SYM
egc-267	100	15	3612	3612	NUM
egc-267	100	16	81	81	NUM
egc-267	100	17	|	|	ADV
egc-267	100	18	p	p	ADP
egc-267	100	19	a	a	DET
egc-267	100	20	g	g	NOUN
egc-267	100	21	e	e	NOUN
egc-267	100	22	references	reference	NOUN
egc-267	100	23	:	:	PUNCT
egc-267	101	1	1	1	X
egc-267	101	2	.	.	X
egc-267	101	3	davis	davis	PROPN
egc-267	101	4	he	he	PRON
egc-267	101	5	,	,	PUNCT
egc-267	101	6	mccorkell	mccorkell	PROPN
egc-267	101	7	l	l	NOUN
egc-267	101	8	,	,	PUNCT
egc-267	101	9	vogel	vogel	PROPN
egc-267	101	10	jm	jm	PROPN
egc-267	101	11	,	,	PUNCT
egc-267	101	12	topol	topol	PROPN
egc-267	101	13	ej	ej	PROPN
egc-267	101	14	.	.	PROPN
egc-267	101	15	long	long	PROPN
egc-267	101	16	covid	covid	PROPN
egc-267	101	17	:	:	PUNCT
egc-267	101	18	major	major	ADJ
egc-267	101	19	findings	finding	NOUN
egc-267	101	20	,	,	PUNCT
egc-267	101	21	mechanisms	mechanism	NOUN
egc-267	101	22	and	and	CCONJ
egc-267	101	23	recommendations	recommendation	NOUN
egc-267	101	24	.	.	PUNCT
egc-267	102	1	nat	nat	PROPN
egc-267	102	2	rev	rev	PROPN
egc-267	102	3	microbiol	microbiol	PROPN
egc-267	102	4	.	.	PUNCT
egc-267	103	1	2023	2023	NUM
egc-267	103	2	mar;21(3):133	mar;21(3):133	NUM
egc-267	103	3	-	-	SYM
egc-267	103	4	146	146	NUM
egc-267	103	5	.	.	PUNCT
egc-267	103	6	doi	doi	NOUN
egc-267	103	7	:	:	PUNCT
egc-267	103	8	10.1038	10.1038	NUM
egc-267	103	9	/	/	SYM
egc-267	103	10	s41579	s41579	NOUN
egc-267	103	11	-	-	PUNCT
egc-267	103	12	022	022	NUM
egc-267	103	13	-	-	PUNCT
egc-267	103	14	00846	00846	NUM
egc-267	103	15	-	-	SYM
egc-267	103	16	2	2	NUM
egc-267	103	17	.	.	PUNCT
egc-267	104	1	epub	epub	PROPN
egc-267	104	2	2023	2023	NUM
egc-267	104	3	jan	jan	PROPN
egc-267	104	4	13	13	NUM
egc-267	104	5	.	.	PUNCT
egc-267	105	1	erratum	erratum	PROPN
egc-267	105	2	in	in	ADP
egc-267	105	3	:	:	PUNCT
egc-267	105	4	nat	nat	PROPN
egc-267	105	5	rev	rev	PROPN
egc-267	105	6	microbiol	microbiol	PROPN
egc-267	105	7	.	.	PUNCT
egc-267	106	1	2023	2023	NUM
egc-267	106	2	jun;21(6):408	jun;21(6):408	PROPN
egc-267	106	3	.	.	PUNCT
egc-267	107	1	doi	doi	NOUN
egc-267	107	2	:	:	PUNCT
egc-267	107	3	10.1038	10.1038	NUM
egc-267	107	4	/	/	SYM
egc-267	107	5	s41579023	s41579023	NUM
egc-267	107	6	-	-	PUNCT
egc-267	107	7	00896	00896	NUM
egc-267	107	8	-	-	PUNCT
egc-267	107	9	0	0	NUM
egc-267	107	10	.	.	PUNCT
egc-267	108	1	pmid	pmid	NOUN
egc-267	108	2	:	:	PUNCT
egc-267	108	3	36639608	36639608	NUM
egc-267	108	4	;	;	PUNCT
egc-267	108	5	pmcid	pmcid	NOUN
egc-267	108	6	:	:	PUNCT
egc-267	108	7	pmc9839201	pmc9839201	NOUN
egc-267	108	8	.	.	PUNCT
egc-267	109	1	2	2	X
egc-267	109	2	.	.	X
egc-267	109	3	jason	jason	PROPN
egc-267	109	4	la	la	PROPN
egc-267	109	5	,	,	PUNCT
egc-267	109	6	dorri	dorri	PROPN
egc-267	109	7	ja	ja	PROPN
egc-267	109	8	.	.	PUNCT
egc-267	110	1	me	i	PRON
egc-267	110	2	/	/	SYM
egc-267	110	3	cfs	cfs	PROPN
egc-267	110	4	and	and	CCONJ
egc-267	110	5	post	post	ADJ
egc-267	110	6	-	-	ADJ
egc-267	110	7	exertional	exertional	ADJ
egc-267	110	8	malaise	malaise	NOUN
egc-267	110	9	among	among	ADP
egc-267	110	10	patients	patient	NOUN
egc-267	110	11	with	with	ADP
egc-267	110	12	long	long	ADJ
egc-267	110	13	covid	covid	PROPN
egc-267	110	14	.	.	PUNCT
egc-267	111	1	neurol	neurol	PROPN
egc-267	111	2	int	int	PROPN
egc-267	111	3	.	.	PUNCT
egc-267	112	1	2022	2022	NUM
egc-267	112	2	dec	dec	PROPN
egc-267	112	3	20;15(1):1	20;15(1):1	NUM
egc-267	112	4	-	-	SYM
egc-267	112	5	11	11	NUM
egc-267	112	6	.	.	PUNCT
egc-267	113	1	doi	doi	NOUN
egc-267	113	2	:	:	PUNCT
egc-267	113	3	10.3390	10.3390	NUM
egc-267	113	4	/	/	SYM
egc-267	113	5	neurolint15010001	neurolint15010001	NOUN
egc-267	113	6	.	.	PUNCT
egc-267	114	1	pmid	pmid	NOUN
egc-267	114	2	:	:	PUNCT
egc-267	114	3	36648965	36648965	NUM
egc-267	114	4	;	;	PUNCT
egc-267	114	5	pmcid	pmcid	PROPN
egc-267	114	6	:	:	PUNCT
egc-267	114	7	pmc9844405	pmc9844405	NUM
egc-267	115	1	3	3	X
egc-267	115	2	.	.	PUNCT
egc-267	115	3	komaroff	komaroff	PROPN
egc-267	115	4	al	al	PROPN
egc-267	115	5	,	,	PUNCT
egc-267	115	6	lipkin	lipkin	PROPN
egc-267	115	7	wi	wi	PROPN
egc-267	115	8	.	.	PUNCT
egc-267	116	1	me	i	PRON
egc-267	116	2	/	/	SYM
egc-267	116	3	cfs	cfs	PROPN
egc-267	116	4	and	and	CCONJ
egc-267	116	5	long	long	ADJ
egc-267	116	6	covid	covid	NOUN
egc-267	116	7	share	share	VERB
egc-267	116	8	similar	similar	ADJ
egc-267	116	9	symptoms	symptom	NOUN
egc-267	116	10	and	and	CCONJ
egc-267	116	11	biological	biological	ADJ
egc-267	116	12	abnormalities	abnormality	NOUN
egc-267	116	13	:	:	PUNCT
egc-267	116	14	road	road	NOUN
egc-267	116	15	map	map	NOUN
egc-267	116	16	to	to	ADP
egc-267	116	17	the	the	DET
egc-267	116	18	literature	literature	NOUN
egc-267	116	19	.	.	PUNCT
egc-267	117	1	front	front	PROPN
egc-267	117	2	med	med	PROPN
egc-267	117	3	(	(	PUNCT
egc-267	117	4	lausanne	lausanne	PROPN
egc-267	117	5	)	)	PUNCT
egc-267	117	6	.	.	PUNCT
egc-267	118	1	2023	2023	NUM
egc-267	118	2	jun	jun	PROPN
egc-267	118	3	2;10:1187163	2;10:1187163	NUM
egc-267	118	4	.	.	PUNCT
egc-267	118	5	doi	doi	NOUN
egc-267	118	6	:	:	PUNCT
egc-267	118	7	10.3389	10.3389	NUM
egc-267	118	8	/	/	SYM
egc-267	118	9	fmed.2023.1187163	fmed.2023.1187163	NOUN
egc-267	118	10	.	.	PUNCT
egc-267	119	1	pmid	pmid	NOUN
egc-267	119	2	:	:	PUNCT
egc-267	119	3	37342500	37342500	NUM
egc-267	119	4	;	;	PUNCT
egc-267	119	5	pmcid	pmcid	NOUN
egc-267	119	6	:	:	PUNCT
egc-267	119	7	pmc10278546	pmc10278546	ADJ
egc-267	119	8	.	.	PUNCT
egc-267	120	1	4	4	X
egc-267	120	2	.	.	X
egc-267	120	3	legler	legler	PROPN
egc-267	120	4	f	f	PROPN
egc-267	120	5	,	,	PUNCT
egc-267	120	6	meyer	meyer	PROPN
egc-267	120	7	-	-	PUNCT
egc-267	120	8	arndt	arndt	PROPN
egc-267	120	9	l	l	PROPN
egc-267	120	10	,	,	PUNCT
egc-267	120	11	mödl	mödl	PROPN
egc-267	120	12	l	l	NOUN
egc-267	120	13	,	,	PUNCT
egc-267	120	14	kedor	kedor	PROPN
egc-267	120	15	c	c	PROPN
egc-267	120	16	,	,	PUNCT
egc-267	120	17	freitag	freitag	PROPN
egc-267	120	18	h	h	PROPN
egc-267	120	19	,	,	PUNCT
egc-267	120	20	stein	stein	PROPN
egc-267	120	21	e	e	PROPN
egc-267	120	22	,	,	PUNCT
egc-267	120	23	hoppmann	hoppmann	NOUN
egc-267	120	24	u	u	NOUN
egc-267	120	25	,	,	PUNCT
egc-267	120	26	rust	rust	NOUN
egc-267	120	27	r	r	NOUN
egc-267	120	28	,	,	PUNCT
egc-267	120	29	wittke	wittke	VERB
egc-267	120	30	k	k	PROPN
egc-267	120	31	,	,	PUNCT
egc-267	120	32	siebert	siebert	PROPN
egc-267	120	33	n	n	CCONJ
egc-267	120	34	,	,	PUNCT
egc-267	120	35	behrens	behrens	PROPN
egc-267	120	36	j	j	PROPN
egc-267	120	37	,	,	PUNCT
egc-267	120	38	thiel	thiel	PROPN
egc-267	120	39	a	a	PROPN
egc-267	120	40	,	,	PUNCT
egc-267	120	41	konietschke	konietschke	ADJ
egc-267	120	42	f	f	X
egc-267	120	43	,	,	PUNCT
egc-267	120	44	paul	paul	PROPN
egc-267	120	45	f	f	PROPN
egc-267	120	46	,	,	PUNCT
egc-267	120	47	scheibenbogen	scheibenbogen	NOUN
egc-267	120	48	c	c	NOUN
egc-267	120	49	,	,	PUNCT
egc-267	120	50	bellmann	bellmann	NOUN
egc-267	120	51	-	-	PUNCT
egc-267	120	52	strobl	strobl	NOUN
egc-267	120	53	j.	j.	PROPN
egc-267	120	54	long	long	ADJ
egc-267	120	55	-	-	PUNCT
egc-267	120	56	term	term	NOUN
egc-267	120	57	symptom	symptom	NOUN
egc-267	120	58	severity	severity	NOUN
egc-267	120	59	and	and	CCONJ
egc-267	120	60	clinical	clinical	ADJ
egc-267	120	61	biomarkers	biomarker	NOUN
egc-267	120	62	in	in	ADP
egc-267	120	63	post	post	ADJ
egc-267	120	64	-	-	ADJ
egc-267	120	65	covid-19	covid-19	ADJ
egc-267	120	66	/	/	SYM
egc-267	120	67	chronic	chronic	ADJ
egc-267	120	68	fatigue	fatigue	NOUN
egc-267	120	69	syndrome	syndrome	NOUN
egc-267	120	70	:	:	PUNCT
egc-267	120	71	results	result	NOUN
egc-267	120	72	from	from	ADP
egc-267	120	73	a	a	DET
egc-267	120	74	prospective	prospective	ADJ
egc-267	120	75	observational	observational	ADJ
egc-267	120	76	cohort	cohort	NOUN
egc-267	120	77	.	.	PUNCT
egc-267	121	1	eclinicalmedicine	eclinicalmedicine	NOUN
egc-267	121	2	.	.	PUNCT
egc-267	122	1	2023	2023	NUM
egc-267	122	2	aug	aug	PROPN
egc-267	122	3	19;63:102146	19;63:102146	NUM
egc-267	122	4	.	.	PUNCT
egc-267	123	1	doi	doi	NOUN
egc-267	123	2	:	:	PUNCT
egc-267	123	3	10.1016	10.1016	NUM
egc-267	123	4	/	/	SYM
egc-267	123	5	j.eclinm.2023.102146	j.eclinm.2023.102146	PROPN
egc-267	123	6	.	.	PUNCT
egc-267	124	1	pmid	pmid	NOUN
egc-267	124	2	:	:	PUNCT
egc-267	124	3	37662515	37662515	NUM
egc-267	124	4	;	;	PUNCT
egc-267	124	5	pmcid	pmcid	ADJ
egc-267	124	6	:	:	PUNCT
egc-267	124	7	pmc10469383	pmc10469383	NOUN
egc-267	124	8	.	.	PUNCT
egc-267	125	1	5	5	X
egc-267	125	2	.	.	X
egc-267	125	3	li	li	PROPN
egc-267	125	4	j	j	PROPN
egc-267	125	5	,	,	PUNCT
egc-267	125	6	zhou	zhou	PROPN
egc-267	125	7	y	y	PROPN
egc-267	125	8	,	,	PUNCT
egc-267	125	9	ma	ma	PROPN
egc-267	125	10	j	j	PROPN
egc-267	125	11	,	,	PUNCT
egc-267	125	12	zhang	zhang	PROPN
egc-267	125	13	q	q	PROPN
egc-267	125	14	,	,	PUNCT
egc-267	125	15	shao	shao	PROPN
egc-267	125	16	j	j	PROPN
egc-267	125	17	,	,	PUNCT
egc-267	125	18	liang	liang	PROPN
egc-267	125	19	s	s	PROPN
egc-267	125	20	,	,	PUNCT
egc-267	125	21	yu	yu	PROPN
egc-267	125	22	y	y	PROPN
egc-267	125	23	,	,	PUNCT
egc-267	125	24	li	li	PROPN
egc-267	125	25	w	w	PROPN
egc-267	125	26	,	,	PUNCT
egc-267	125	27	wang	wang	PROPN
egc-267	125	28	c.	c.	PROPN
egc-267	125	29	the	the	DET
egc-267	125	30	long	long	ADJ
egc-267	125	31	-	-	PUNCT
egc-267	125	32	term	term	NOUN
egc-267	125	33	health	health	NOUN
egc-267	125	34	outcomes	outcome	NOUN
egc-267	125	35	,	,	PUNCT
egc-267	125	36	pathophysiological	pathophysiological	ADJ
egc-267	125	37	mechanisms	mechanism	NOUN
egc-267	125	38	and	and	CCONJ
egc-267	125	39	multidisciplinary	multidisciplinary	ADJ
egc-267	125	40	management	management	NOUN
egc-267	125	41	of	of	ADP
egc-267	125	42	long	long	ADJ
egc-267	125	43	covid	covid	PROPN
egc-267	125	44	.	.	PUNCT
egc-267	125	45	signal	signal	PROPN
egc-267	125	46	transduct	transduct	NOUN
egc-267	125	47	target	target	NOUN
egc-267	125	48	ther	ther	ADV
egc-267	125	49	.	.	PUNCT
egc-267	126	1	2023	2023	NUM
egc-267	126	2	nov	nov	NOUN
egc-267	126	3	1;8(1):416	1;8(1):416	NUM
egc-267	126	4	.	.	PUNCT
egc-267	127	1	doi	doi	NOUN
egc-267	127	2	:	:	PUNCT
egc-267	127	3	10.1038	10.1038	NUM
egc-267	127	4	/	/	SYM
egc-267	127	5	s41392	s41392	VERB
egc-267	127	6	-	-	PUNCT
egc-267	127	7	023	023	NUM
egc-267	127	8	-	-	PUNCT
egc-267	127	9	01640	01640	NUM
egc-267	127	10	-	-	PUNCT
egc-267	127	11	z.	z.	NOUN
egc-267	127	12	pmid	pmid	PROPN
egc-267	127	13	:	:	PUNCT
egc-267	127	14	37907497	37907497	NUM
egc-267	127	15	;	;	PUNCT
egc-267	127	16	pmcid	pmcid	ADJ
egc-267	127	17	:	:	PUNCT
egc-267	127	18	pmc10618229	pmc10618229	NOUN
egc-267	127	19	.	.	PUNCT
egc-267	128	1	6	6	X
egc-267	128	2	.	.	X
egc-267	128	3	qanneta	qanneta	PROPN
egc-267	128	4	r.	r.	PROPN
egc-267	128	5	long	long	PROPN
egc-267	128	6	covid-19	covid-19	PROPN
egc-267	128	7	and	and	CCONJ
egc-267	128	8	myalgic	myalgic	ADJ
egc-267	128	9	encephalomyelitis	encephalomyelitis	NOUN
egc-267	128	10	/	/	SYM
egc-267	128	11	chronic	chronic	ADJ
egc-267	128	12	fatigue	fatigue	NOUN
egc-267	128	13	syndrome	syndrome	NOUN
egc-267	128	14	:	:	PUNCT
egc-267	128	15	similarities	similarity	NOUN
egc-267	128	16	and	and	CCONJ
egc-267	128	17	differences	difference	NOUN
egc-267	128	18	of	of	ADP
egc-267	128	19	two	two	NUM
egc-267	128	20	peas	pea	NOUN
egc-267	128	21	in	in	ADP
egc-267	128	22	a	a	DET
egc-267	128	23	pod	pod	NOUN
egc-267	128	24	.	.	PROPN
egc-267	129	1	reumatol	reumatol	PROPN
egc-267	129	2	clin	clin	PROPN
egc-267	129	3	(	(	PUNCT
egc-267	129	4	engl	engl	PROPN
egc-267	129	5	ed	ed	NOUN
egc-267	129	6	)	)	PUNCT
egc-267	129	7	.	.	PUNCT
egc-267	130	1	2022	2022	NUM
egc-267	131	1	dec;18(10):626	dec;18(10):626	NOUN
egc-267	131	2	-	-	PUNCT
egc-267	131	3	628	628	NUM
egc-267	131	4	.	.	PUNCT
egc-267	132	1	doi	doi	NOUN
egc-267	132	2	:	:	PUNCT
egc-267	132	3	10.1016	10.1016	NUM
egc-267	132	4	/	/	SYM
egc-267	132	5	j.reumae.2022.05.001	j.reumae.2022.05.001	PROPN
egc-267	132	6	.	.	PUNCT
egc-267	133	1	pmid	pmid	NOUN
egc-267	133	2	:	:	PUNCT
egc-267	133	3	36435560	36435560	NUM
egc-267	133	4	;	;	PUNCT
egc-267	133	5	pmcid	pmcid	ADJ
egc-267	133	6	:	:	PUNCT
egc-267	133	7	pmc9683473	pmc9683473	NOUN
egc-267	133	8	.	.	PUNCT
egc-267	134	1	7	7	X
egc-267	134	2	.	.	X
egc-267	134	3	wong	wong	PROPN
egc-267	134	4	tl	tl	PROPN
egc-267	134	5	,	,	PUNCT
egc-267	134	6	weitzer	weitzer	NOUN
egc-267	134	7	dj	dj	PROPN
egc-267	134	8	.	.	PUNCT
egc-267	134	9	long	long	PROPN
egc-267	134	10	covid	covid	PROPN
egc-267	134	11	and	and	CCONJ
egc-267	134	12	myalgic	myalgic	ADJ
egc-267	134	13	encephalomyelitis	encephalomyelitis	NOUN
egc-267	134	14	/	/	SYM
egc-267	134	15	chronic	chronic	ADJ
egc-267	134	16	fatigue	fatigue	NOUN
egc-267	134	17	syndrome	syndrome	NOUN
egc-267	134	18	(	(	PUNCT
egc-267	134	19	me	i	PRON
egc-267	134	20	/	/	SYM
egc-267	134	21	cfs)-a	cfs)-a	NOUN
egc-267	134	22	systemic	systemic	ADJ
egc-267	134	23	review	review	NOUN
egc-267	134	24	and	and	CCONJ
egc-267	134	25	comparison	comparison	NOUN
egc-267	134	26	of	of	ADP
egc-267	134	27	clinical	clinical	ADJ
egc-267	134	28	presentation	presentation	NOUN
egc-267	134	29	and	and	CCONJ
egc-267	134	30	symptomatology	symptomatology	NOUN
egc-267	134	31	.	.	PUNCT
egc-267	135	1	medicina	medicina	PROPN
egc-267	135	2	(	(	PUNCT
egc-267	135	3	kaunas	kaunas	PROPN
egc-267	135	4	)	)	PUNCT
egc-267	135	5	.	.	PUNCT
egc-267	136	1	2021	2021	NUM
egc-267	136	2	apr	apr	NOUN
egc-267	136	3	26;57(5):418	26;57(5):418	PROPN
egc-267	136	4	.	.	PUNCT
egc-267	137	1	doi	doi	NOUN
egc-267	137	2	:	:	PUNCT
egc-267	137	3	10.3390	10.3390	NUM
egc-267	137	4	/	/	SYM
egc-267	137	5	medicina57050418	medicina57050418	PROPN
egc-267	137	6	.	.	PUNCT
egc-267	138	1	pmid	pmid	NOUN
egc-267	138	2	:	:	PUNCT
egc-267	138	3	33925784	33925784	NUM
egc-267	138	4	;	;	PUNCT
egc-267	138	5	pmcid	pmcid	PROPN
egc-267	138	6	:	:	PUNCT
egc-267	138	7	pmc8145228	pmc8145228	VERB
egc-267	138	8	.	.	PUNCT
egc-267	139	1	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN